Trustees’ Annual Report and Accounts 2020
Company limited by guarantee registered in England and Wales (4118259).
1
Table of contents
| Table of contents | |
|---|---|
| What we do | 5 |
| What is EB? | 6 |
| Strategic report | 7 |
| Welcome from our Chair & CEO | 8 |
| Charity overview, objectives & public beneft | 12 |
| Pioneering research | 15 |
| International collaboration & best practice | 19 |
| Specialist healthcare | 23 |
| Lifelong community support | 27 |
| Our retail stores | 31 |
| How we raise our funds | 35 |
| Raising awareness | 39 |
| Our people | 43 |
| Financial review | 49 |
| Principal risks & uncertainties | 56 |
| Going concern statement | 58 |
| Structure, governance & management | 60 |
| Trustees’ statement of responsibilities | 67 |
| Auditor’s report | 68 |
| Financial statements | 73 |
| Statement of fnancial activities | 74 |
| Balance sheet | 76 |
| Cash fow statement | 78 |
| Notes to the accounts | 79 |
| Reference and administrative details | 108 |
| Abbreviations | 109 |
Our vision
A world where no one suffers from the painful skin condition Epidermolysis Bullosa (EB)
Our mission Provide lifelong care and support to everyone in the UK affected by EB
Our aims Fund pioneering research for symptom alleviation and ultimately a cure
Provide care and support to the entire EB community Together we #FightEB
2
3
What we do
DEBRA is the national charity supporting those living with or directly affected by EB. We have achieved global recognition as a leader on EB and are the only UK charity specifically aimed at continuously supporting the EB community.
Phyllis Hilton, whose daughter Debra had EB, set up the charity in 1978 as the world’s first EB patient support group. We have come a long way since then, working internationally through a network of nearly 50 DEBRA groups to share information and best practice.
We fund pioneering research, provide specialist healthcare, promote best practice and deliver lifelong support to individuals, families and the entire EB community. Our support includes:
-
providing practical, financial and emotional support and advocacy for people with EB and their families
-
partnering with the NHS to provide specialist care and clinical care guidelines
-
working with researchers to find a cure(s) and alleviate the debilitating effects of living with EB
-
investing in our Community Support Team to allow us to share knowledge, skills and experience to empower and enable achievements within the EB community
-
expanding and strengthening family health and community support networks to improve quality of care.
Supporting DEBRA – through fundraising activities, direct donations, purchasing items in the retail shops or offering time as a volunteer – has a direct impact on the support we offer the EB community.
Investing in a future free of EB
While our vision is for a future where no one suffers from EB, until that day arrives we work tirelessly to improve quality of life for the entire EB community.
DEBRA UK funds:
-
Specialist healthcare
-
Pioneering research
-
Community support
-
International best practice
4
5
What is EB?
EB is a potentially fatal skin condition that causes constant pain due to continuous internal and external blistering. With EB, skin is so fragile that it can tear at the slightest touch and for this reason it is sometimes called ‘butterfly skin’. There are an estimated 5,000 people affected by EB in the UK and 500,000 worldwide.
In its most severe forms, EB is fatal; even in its mildest forms it can cause lifelong disability and pain. Blisters continuously form and have to be drained and dressed daily, a painful process that can take several hours. Repeated blistering results in the build-up of scar tissue which can cause fingers and toes to fuse together and can mean a higher risk of developing skin cancer. The debilitating effects of EB inevitably impact the mind as well, leading to psychological challenges. EB is currently incurable.
----- Start of picture text -----
Louise Bellaers Photography
----- End of picture text -----
Strategic report Highlights of DEBRA’s services and income generation activities in 2020 and an overview of future plans
6
7
Welcome from our Chair
When I was preparing my statement for last year’s (2019) Annual Report we were in the early days of coping with the coronavirus pandemic and had just entered the first UK national lockdown. I said then that “the outcomes are currently uncertain and they will ultimately shape our ambitions for the years ahead” and “we are financially strong and fully expect to come through the crisis fully intact”. None of us had any real idea back then about how big an impact COVID-19 would, and continues to, have but twelve months on we can start to have a level of optimism that the worst might well be behind us, allowing us to focus on the future once more.
I am delighted to report that, despite a significant hit to our financial strength during 2020, our objectives are unchanged. DEBRA continues to focus on improving the quality of life for those living with all types of EB as we invest in world-leading research towards finding cures.
Our financial strength allowed us to meet our existing research commitments and during the year we approved a further spend of £764,000 on some exciting new projects including investing £191,000 into the biopharmaceutical company FIBRX Derm Inc. Meanwhile, our wonderful Community Support Team had to adapt and learn almost overnight how to provide care remotely. Retail income took a hammering and, with over 300 retail staff and significant lease commitments to meet, we were hugely grateful for the various levels of government support that allowed us to keep our portfolio intact. Fundraising from events had a great start to the year and despite being seriously curtailed from March still managed some real successes. We made real progress in legacies with growth from £185,000 in 2019 to £257,000 in 2020.
I was hugely disappointed that we had to cancel our Members’ Weekend in 2020 but the safety of our community dictated that we had no option. We are committed to restarting that event, and others, when it is safe to do so but in the meantime we will continue to embrace technology that allows us to engage remotely with our community.
The year had started in spectacular fashion with the EB 2020 World Congress, hosted and primarily funded by DEBRA, in London during
January. With 730 delegates representing 215 organisations from 54 countries, it was by far the largest gathering of EB community, professionals and bio-pharma companies that has ever taken place. The conference was a huge success and it is worth reflecting on just how far DEBRA has come since being established as a parent support group in 1978. Under the guidance and governance of our Trustees and with the leadership of our new CEO, Tony Byrne, we are all committed to playing a leading role in collaborating internationally to #Fight EB.
My closing words from last year’s statement reflected on the fantastic support we receive from our army of volunteers and the resilience and strength of character of the entire EB community. Those words resonate as loudly today as they did then as we seek to find our ‘new normal’ and continue to fight, and ultimately beat, EB.
Jim Irvine
Chair of Trustees
8
9
Welcome from our CEO
I was delighted to join DEBRA in October 2020, an ‘interesting’ time to join any organisation. The UK had already undergone one major lockdown and many of DEBRA’s team members were working from home or furloughed. In November and then at the end of December we entered the second and third lockdowns, however I was still able to meet team members and the EB community during this time. Most, if not all, meetings have been conducted virtually and I have been impressed by how DEBRA and our members have utilised technology, adapted and met the challenges of the pandemic.
The year has been difficult for our members, colleagues, volunteers and supporters. It has been financially challenging, with our sources of income severely curtailed from the closure of our retail stores and the cancellation and postponement of our fundraising events.
We have been grateful for the continued support of our donors, the support of our fundraisers and the donations received from the limited events we have been able to run in a Covid-safe manner. The DEBRA team have risen to the challenge, with at times over 90% of the team furloughed either full or part-time. They have in these uncertain times worked tirelessly for the benefit of our members.
Our priority focus has always been to support those affected by EB.
Our Community Support Team have reached out to our members through individual phone calls, and virtually via online platforms and through social media, ensuring information and support is always available. We continued to invest £839,000 in membership and community support activities in 2020.
We continued our support for EB nurses with up to 25% of their costs being met by DEBRA and supporting healthcare with a further investment of £347,000.
Our funding of research into cure and care did not cease in 2020: we invested £1.181m in our continued search for answers to cure this terrible condition.
As we look to the future, we have introduced a Management and Performance (MAP) process which aligns our objectives to our business plan and gives clarity and focus on what and how we are delivering against our goals.
We are undertaking a review of our IT systems, our policies and procedures and the way we support and listen to our members and our teams. Our aim is to learn from the pandemic, understanding how it affected the way we work. We will apply this learning to improve our ways of working, to improve how we support our members, colleagues, volunteers and supporters, to help us find better treatments for the care of our members and, ultimately, to find the cure our members need to #FightEB.
Finally, we look back with gratitude. We are so proud of how our staff and volunteers worked together throughout 2020. Our heartfelt thanks go to them, to the extraordinary generosity and commitment of our supporters, the brilliant community of EB specialists and healthcare professionals and, above all, the individuals and families living with EB. Thank you.
Together we will continue to #FightEB in 2021.
Tony Byrne
CEO
10
11
Charity overview
DEBRA is the national charity (incorporated in the UK) supporting everyone in the UK affected by EB. We are registered with the Charity Commission for England and Wales, as well as the Office of the Scottish Charity Regulator (OSCR) in support of our Scottish activities that continue to form an important part of DEBRA’s UK strategy. The financial statements comply with current statutory requirements, the memorandum and articles of association, the requirements of a directors’ report as required under company law, and the Statement of Recommended Practice - Accounting and Reporting by Charities: SORP applicable to charities preparing their accounts in accordance with FRS 102.
Like many charities, our income from our retail shops, fundraising and Gift Aid was affected by the pandemic. Despite this, throughout the year our amazing supporters, volunteers and staff gave us unwavering support. We receive no statutory government funding, but we were able to take full advantage of government incentives such as the Coronavirus Job Retention Scheme.
Our objectives
The 2021-22 Business Plan sets DEBRA’s course for the next two years, ensuring it remains on a solid financial footing. In parallel, the Trustee Board and Senior Management Team are charting an ambitious five-year strategy to deliver some significant goals by 2026 including:
- playing a pivotal role in coordinating research into EB, a global exercise with DEBRA front and central in leading the quest for a cure
support available. This includes through taking part in satisfaction and service development surveys, group discussions as well as the DEBRA patient panel made up of members of the EB community who help review research projects.
Our Care & Research Committee makes strategic and fundamental recommendations on the charitable activities undertaken by DEBRA for the benefit of sufferers of any type of EB.
The Trustees have referred to the guidance contained in the Charity Commission’s general guidance on public benefit when reviewing the charity’s aims and objectives and in planning its future activities. In particular, the Trustees consider how planned activities will contribute to the aims and objectives that have been set.
My son Jamie has generalised severe EB. He was born with no skin on his feet, knees and hands and even where there was intact skin, it blistered. It was so hard to bond - I didn’t hold my baby for the first six months. He is the first person in my family to have EB so it came as an enormous shock.
The most difficult thing about EB is seeing your child in pain, knowing that the care you are giving is causing so much distress. The community support I have received from DEBRA has been outstanding and makes a real difference.
-
reconfiguring how we will care for our members, ensuring they are centremost in our long-term plans
-
refocusing our fundraising efforts, recognising that the short and long-term effects of the pandemic mean that there will be less reliance on events and more reliance on building long-term relationships
Katie White, mother of Jamie White living with EB
-
building a more efficient and leaner retail function
-
increasing brand awareness across all of our audiences
-
continuing to develop the skills and knowledge of our people
-
ensuring that our operations, governance and risk management are best in class.
Public benefit
DEBRA meets the definition of a public benefit entity under FRS102, s17 of the Charities Act 2011 and Charity Commission and OSCR guidelines. We provide support to people across the UK living with any type of EB, as well as family members and carers of someone who has EB and those working within the EB community in a professional capacity.
Members affected by EB are encouraged to engage with us to further develop our services and the
12
13
Pioneering research
Despite concerns surrounding the pandemic, we were able to approve a total of £764,000 for research projects in 2020, spending £573,000 on new research projects and investing £191,000 into the biopharmaceutical company FIBRX Derm Inc., which is researching an EB therapy.
We continue to be strategically focused on investing in pioneering research to find cures and treatments for EB that will significantly improve quality of life.
Research strategy
Our research strategy of striving to achieve cures, manage symptoms and improve quality of life has been maintained within the expanding global focus on EB research. We continue to invest in research into clinical, scientific and pharmacoeconomic endpoints that will support the regulatory pathways for treatment approvals in the future.
The current portfolio of research projects includes pre-clinical laboratory work, research into gene and cell therapies and drug re-purposing, as well as projects driving a change in symptom relief for wound healing and cancer therapy. It is critical to ensure there is a balance of research into all types of EB represented in our community. We also support fellowships, helping to develop and shape our researchers and clinical experts for the future.
Key areas
Developing a novel gene technology for EBS treatment
We are proud to continue funding the ongoing work by researchers at the University of Dundee, including a DEBRA Clinical Research Fellow. This pre-clinical study aims to develop methods for using gene silencing technology as a therapeutic option in clinic for people with Epidermolysis Bullosa Simplex (EBS). There are also hopes for wider application for other types of EB.
In 2017 Simon and Karen Talbot lost their son Dylan to Junctional EB aged 3 months and 1 day.
Defining relevant clinical endpoints
In 2018, we learnt Karen was pregnant. EB is inherited and we were both carriers of the gene and this meant it was likely our baby would have the same type of EB Dylan had. Thanks to advances in EB research and funding from DEBRA, we were able to test our baby for EB before she was born. Knowing we would not have to see our new-born go through the same pain and distress Dylan did was a massive relief. Our baby girl was born on 4 November 2018, EB free. We named her Katie Rose Talbot after the EB Nurse Specialist at Great Ormond Street Hospital – Katie Plevey. She was such a big part of family life with Dylan that we wanted her to be forever part of our family. Rose is also Dylan’s birth month flower, so her name is very special.
Simon & Karen Talbot, EB parents
Since 2013, we have committed £735,000 to a project that aims to better understand the progression of Recessive Dystrophic EB (RDEB) by identifying and defining relevant clinical endpoints that could be measurable target outcomes for EB clinical trials. This work is ongoing, and it is hoped that it will ultimately help future clinical trials for all types of EB.
Investing in industry for potential treatments
In 2020, we made our first investment into a biotechnology firm, FIBRX Derm Inc. in support of a study that aims to continue research (originally funded by DEBRA) investigating a naturally occurring protein that may serve as a viable anti-scarring therapy for people living with DEB (Dystrophic EB) and which could be administered topically. The company has received financial support from the US Department of
14
15
Defense and multiple EB groups across the world, supporting our desire to take the lead in international collaboration.
Understanding immunity and fibrosis
DEBRA UK and DEBRA Ireland have committed to co-funding research to evaluate the inflammatory response in people living with RDEB. This study is investigating the sequence of immune responses to understand how chronic inflammation and fibrosis develop with the aim of identifying potential treatment options.
Understanding cell behaviour to help determine potential therapies
Ongoing research funded by DEBRA UK aims to understand the mechanism of how TGF-ß (protein) signalling can lead to cancer migration, invasion and tumour growth, as well as identify how the molecular characteristics (biomarkers) of TGF-ß behave in RDEB skin cancer, both of which may help to determine potential therapies.
Driving research globally
The EB World Congress, the flagship global conference on EB, was organised and majority funded by DEBRA UK with contributions from other EB groups. It was held in London at the end of January 2020 and attended by more than 700 individuals including key stakeholders from industry, researchers, clinicians, patients and EB groups. The inaugural Congress was more than double the size of any previous international EB research/care conference. The data presented represented the latest in research and clinical management. All other EB research funding bodies participated and over 20 biotechnology companies sponsored and attended the meeting, all with a focus on cures, treatment and management strategies for the EB community.
We welcome partnerships and collaboration with other EB organisations under the mutual aims of finding cures for the EB community. Communication and coordination are critical to the success of continued international research projects, both in direction and funding.
2020 Research by numbers
-
£573,000 committed to new research projects
-
£608,000 spent on other research activities
-
£191,000 invested in a biotech company
Looking to the future
We recognise that the support of a wide range of research into cures and treatment is critical to achieving our aims. As such, we will continue to use expert summits to identify new research opportunities. Due to the pandemic, we were unable to participate in the autumn 2020 grant round for funding EB research projects; however, we plan to continue proactively identifying projects and developing and enhancing our funding strategies for the future.
Working hand in hand with industry and academia is key to bringing research developments into routine clinical practice, paving the way for health and technology assessments.
Our research aims for 2021
-
Invest circa £250,000 in research projects in 2021 to help maintain our ongoing project portfolio, with a view to increasing investments where possible.
-
Focus on the translation of pre-clinical research into early phase patient studies identifying suitable treatments for cures and control of EB, as well as symptom relief and treatments that will impact positively on quality of life.
-
Link our research strategy of striving to achieve cures, manage symptoms and improve quality of life with DEBRA International’s research strategy.
-
Continue to proactively identify core areas for research and enhance the EB clinical and research community.
-
Champion communication, co-ordination and collaboration to ensure a coherent approach to EB research globally.
-
Work with other EB groups to co-fund future research that provides continuity for currently funded research.
I was first introduced to the traumatic plight of EB sufferers several years ago and I felt compelled to contribute to the global research effort dedicated to developing treatments for patients ever since. EB is an excruciatingly painful skin blistering disorder that is inherited and affects children from birth. The more aggressive forms of EB are further complicated by the onset of dangerous life-threatening skin cancers which are very difficult to effectively treat.
-
19 ongoing research projects funded by DEBRA UK
-
£8.1m spent on research grants over the last 10 years
-
7 projects co-funded with other DEBRA groups and one with a pharmaceutical company
It is vital that we raise both awareness of EB and funds to develop new treatments to alleviate the suffering that both patients and their families currently have to bear.
Professor Gareth Inman, CI UK Beatson Institute, University of Glasgow
16
17
International collaboration and best practice
EB is a condition that can affect anyone in any part of the world. Therefore, international collaboration and coordination of research and projects are vital in developing effective treatments and potential cures for EB. We work closely with other national DEBRAs as well as with external groups to ensure our research efforts are effectively coordinated and best practice information is shared with all relevant parties – including researchers, clinicians, other charities, pharmaceutical companies and biotechnology organisations.
Collaborating at the international level
Our strategy for international collaboration is to:
-
build on the success of the flagship conference, EB 2020 World Congress
-
improve international clinical care practices by developing and maintaining an up-to-date multi-lingual library reviewing all existing literature and detailing current best practice treatment and care for all aspects of EB
-
improve clinical care through developing clinical networks, sharing knowledge and training
-
raise awareness of EB and the care required by advocating on behalf of the UK EB community and membership
-
ensure that all DEBRA funded research is peer reviewed by the DEBRA Medical & Scientific Research Panel
-
improve joint working on communication, campaigns and projects
-
review possible partnerships with promising biotech start-ups on a case-by-case basis.
Key areas
Coordinating international research projects
DEBRA UK is a founding member of DEBRA International, our umbrella organisation with nearly 50 members groups in other countries that aims to ensure all EB research and care activities are coordinated worldwide where possible. We work alongside DEBRA International to manage the Research Involvement Network, which aims to inform members of developments in EB research and promote its importance and opportunities for patient involvement.
Enhancing global EB care and best practice
Alongside other members of DEBRA International, we assist in the development of an international EB Patient Registry and Clinical Practice Guidelines (CPGs). Aimed at clinicians, these guidelines are often citable articles published in professional journals. Most guidelines are now also available as patient versions, which are written to help people living with EB to understand and implement the guidance and
18
19
advice, and some have been translated into other languages. In 2020, we committed funding to three new CPGs – CAIMS (Complementary & Integrated Medicines), Palliative Care and Neonatal Care.
Raising EB awareness around the world
Working with DEBRA International groups, we aim to raise the profile of EB significantly in the coming years through integrated and coordinated awareness campaigns. As an example, in 2020, in collaboration with DEBRA International, we developed a simplified ‘What is EB’ infographic that was shared with and used by other national DEBRA groups during the global 2020 EB Awareness Week campaign.
Enhancing clinical and research knowledge
We annually fund training grants through the Professor Robin Eady Grant fund to assist clinicians and researchers in furthering their professional development and their interest in the field of EB. The pandemic prevented us from awarding the grant in 2020 due to global travel restrictions and constraints on clinicians’ time, which meant that professionals were unable to attend in-person meetings and training events. In 2021 we plan to support more virtual international training events and meetings.
Looking to the future
Working with DEBRA International, DEBRA UK plans to bolster its activities through further funding of services, particularly with the development of international CPGs and the international EB Patient Registry.
Our international collaboration aims for 2021
-
Continue joint funding the development of international CPGs.
-
Participate in the development of international research strategy and discussion with all EB charities.
-
Improve joint working on communication, campaigns and projects that can be of benefit to the global DEBRA community.
-
Work with other research groups to ensure information sharing and to prevent duplication.
-
Ensure information on research is easily available to members, professionals and industry.
-
Consider plans for the next EB World Congress event.
Significant partnerships
We support a small number of international projects and contribute to the running costs of DEBRA International through a subscription as well as giving time and expertise to support DEBRA International. DEBRA UK ensures good value is received from DEBRA International’s activities with progress reports outlining delivery of DEBRA UK-funded projects.
DEBRA International coordinates the CPG programme and manages the EB Without Borders (EBWB) group, a collaborative effort to assist EB sufferers in need around the world, particularly in locations that do not have a national DEBRA organisation. DEBRA UK and UK clinicians work closely with the EBWB Team on a referral basis.
International by numbers
-
Some 50 national DEBRA groups established around the world
-
420 Members of the Clinical Practice Guidelines Network
-
602 individuals in the DEBRA International Research Involvement Network
-
8 international CPGs funded by DEBRA UK
-
17 global EB research sites funded by DEBRA UK
-
3 national DEBRA groups co-funding research with DEBRA UK
20
21
Specialist healthcare
We provide funding to deliver a UK-wide specialist healthcare service for people living with any type of EB. This service is provided in partnership with NHS England’s Specialised Services Commissioning Team and NHS Scotland who fund the core (NHS duty of care) clinical service.
EB Centres of Excellence
There are four designated EB Centres of Excellence in the UK based at hospitals in Birmingham and London: Birmingham Women’s and Children’s Hospital, Solihull Hospital, Great Ormond Street Children’s Hospital and St Thomas’ Hospital.
Multidisciplinary teams consisting of DEBRA Community Support Managers, consultants, EB nurses and other specialist healthcare professionals meet at these centres to provide the high levels of expertise required to care for people living with EB.
Key areas
Podiatry
Even in its milder form, EB affects the hands and feet of most sufferers, yet there is very little awareness among the podiatric community about the condition. To address this, in 2017 we committed £105,000 over three years to fund the development of an accredited EB podiatry training course, as well as a full training programme across the UK, enabling people suffering from EB to receive more expert care and improve their quality of life. In 2019, the first training course took place in London and the EB podiatry network was established. However, due to the coronavirus pandemic, further training and development of the network has been on hold but will restart in 2021.
Clinical teams
EB certainly runs in my family. My dad was in the army but got a medical discharge during the war due to EB. My brother has EB as does his daughter and her three children. And my daughter also has it. Back then EB was just called blisters. My symptoms were the same as my dad’s and when it got bad dad would use a needle and wool to burst the blisters on my hands and drain them. The treatments for EB have really improved over the years. When I was younger, my feet were saturated in blisters and the podiatrist used a rough scrubber to remove the skin. He had no idea what EB was. Today of course we have specialist bandages and creams to ease the pain. I was introduced to DEBRA by one of my doctors at St Thomas’ Hospital. DEBRA has really helped me. I finally had some support and I got to meet and speak to people who knew about my condition and what I was going through. People ask me how I have coped with such a painful condition, but you just get on with it. You can’t let anything beat you.
Terry Cook, living with EBS
The pandemic placed enormous pressures on all clinicians across the UK in 2020. Yet the teams worked immensely hard to ensure a specialist EB service remained accessible, even when those teams were on standby or were redeployed to help the fight against the pandemic. A combination of virtual and in-person clinics and care were offered and teams continued to provide specialist EB training to enable professional development, and knowledge and experience in the field of EB, to be maintained at the highest standard within the wider healthcare practice.
Nursing
Our funding of the two paediatric designated Centres of Excellence continued in 2020 with the funding of an additional two-year fixed-term nursing post at each location. Following multiple retirements and vacancies, this funding will support the establishment of the new teams and ensure that they have the time to undertake the required clinical specialist training. These posts have also assisted with providing care to an increasing number of patients at each centre.
22
23
Rare Diseases Centre
The Rare Diseases Centre at St Thomas’ Hospital (supported by £250,000 of DEBRA funding) continues to greatly enhance the clinical facilities available to the EB community and enable the development of multi-disciplinary working. These facilities have enabled the operation of virtual clinics and have reduced movement across clinical settings as the centre has multiple facilities including a small skin surgery room. We continue to support all the UK’s EB Centres of Excellence through lobbying and/or funding to ensure that the appropriate facilities and equipment are available for all EB patients.
Healthcare by numbers
-
2,000 patients supported by EB specialists
-
100 days of specialist dietitian services
-
10 clinical supervision workshops
-
Up to 25% of specialist EB nurses’ costs covered by DEBRA
-
£347,000 spent on healthcare
-
18 different TV grants covering 141 inpatient days
-
14 specialist EB training days
Looking to the future
We will continue to review our support plans to meet the changing needs of the EB community and to address the uncertainty caused by the pandemic.
Our healthcare aims for 2021
-
Encourage and support innovative clinical practice and service developments that will enhance the lives of those affected by EB.
-
Update and enhance the range of information and publications and improve the accessibility of information available to members and healthcare professionals.
24
25
At the start of the coronavirus pandemic, our Community Support Team arranged immediate delivery of a free emergency food parcel and found a supplier able to provide Scott with regular food delivery slots. They investigated local sources of PPE for his carers and had a delivery confirmed for him within 48 hours. They also asked him if he would work with DEBRA to create a motivational video showing other EB sufferers how to cope with isolation, and help Scott himself feel more connected.
Lifelong community support
We provide membership and specialist community support services to people across the UK. Liaising directly with members of the EB community is vital to understanding the needs of EB sufferers and those impacted by the condition.
Engaging with the EB community
We consistently request and review feedback from our members through surveys, focus groups and general meetings. Some of the topics include programme requests for member events, new projects and publications. The 2020 virtual member groups identified that members like what we are currently doing but would like us to increase or improve peer support, sharing of research updates, printed materials and website content and functionality. These requests are all within our plans for improvement.
Key areas
Information and liaison support
We are committed to delivering support to improve quality of life for the EB community.
We offer a range of benefits to our members and support from a dedicated, expert team which can advocate and advise on topics from welfare rights reform, housing and employment to education and independent living. These services are provided based on feedback received from the EB community. We continue to focus on contacting people suffering from EB who are not taking advantage of the services to enable them to do so.
When the pandemic started early in 2020, the planned development of the Community Support Team and additional activities were postponed in order to focus on supporting members’ immediate needs within the funding available. Members with severe EB received a well-being call and all members received an email or letter to ensure they had the support they required as we entered lockdowns at the start and end of the year. Throughout the remainder of 2020 the team continued to offer a service across the UK, predominantly remotely but where necessary in person. At times, a number of team members were working reduced weekly hours and were placed on flexi-furlough but all urgent and essential requests for support were fulfilled.
Support grants
I am in self-isolation, in fact strict “shielding” and can’t leave my home because of my condition, EB. Without DEBRA’s emergency food package I would be without food. They helped to set me up with a local food service long term and arranged a food package immediately to stop me from going hungry before this service was in place. I cannot thank them enough.
We provide support grants to members for emerging needs and to assist in covering costs for basic quality of life improvements, such as white goods and new-born baby goods. In addition to DEBRA support grants, the Community Support Team have successfully helped members of the EB community to access financial support from other sources.
Scott O’Sullivan, living with RDEB
26
27
Community events
Instances of members of the EB community feeling isolated and alone increased in 2020 due to the impact of the pandemic. We responded by providing opportunities across the UK for our members to meet, share experiences and learn how others manage the condition. As all in-person events were cancelled, a range of virtual groups were quickly set up to facilitate peer support, share insights and information and engage with members. This helped us to gain an understanding of current needs and prioritise the work of the charity. The virtual meetings were well received. In some cases, they helped develop IT skills and confidence to use technology for keeping in touch with family/friends and on-line shopping which was important due to the restrictions caused by the pandemic.
We will review and develop our publications and the use of multimedia to improve the sharing of information. We plan to develop a more detailed understanding of the EB community to help achieve a more proactive service and to maintain the aspects of the remote service that have worked well for members and the team, alongside in-person activity.
The search for a new holiday home for 2023 will begin. We will continue to deliver a support and membership service with the current team, prioritising urgent and essential support if the membership grows or if the demand for support increases.
Our community support aims for 2021
Respite care
Having the opportunity to go on holiday may be out of reach for many people within the EB community because of cost or lack of adequate specialised facilities. At times during 2020, all of our holiday homes were closed in line with government rules. Some members were apprehensive about travelling and the uncertainty of the situation. However, despite this, 71 weeks of holiday were taken by 478 members in 2020 in the six DEBRA holiday homes. In September one of the holiday homes at Weymouth was sold for trade use as it had reached its maximum age. Feedback from members continues to be very positive about all homes, the range of locations and their facilities.
Significant partnerships
We work with, and are members of, other organisations – including DEBRA International, Disability Rights UK and Carers UK – to enhance the services available to the EB community.
Community support by numbers
-
1,195 individuals accessed the DEBRA Community Support service
-
1,078 Covid well-being calls made to members
-
154 support grants awarded to value of £24,000
-
Provide a professional membership and community support service to members of the EB community across the UK.
-
Develop the Membership and Community Support Teams to meet current and future needs that may arise as a result of the coronavirus pandemic – for example if unemployment rises the need for support regarding benefits is likely to increase.
-
Ensure that sufficient funds remain available within the support grant budget allowing for the projected rise in applications for urgent and essential goods and services.
-
Encourage and support innovative research projects and service developments that will enhance the lives of those affected by EB.
-
Review the membership model, increase membership numbers, diversity and engagement of members and undertake a survey of service satisfaction.
-
Facilitate an enhanced range of virtual peer support and membership activities including virtual member events and AGM.
-
Explore the opportunities available to set up a volunteer befriending network.
-
Publish a report on the achievements and support available for the EBS community.
-
Publish a report on the non-medical achievements and support available to members of the EB community, positioning us as the go-to EB charity and engaging new and current audiences.
-
76 virtual members groups held
-
£839,000 spent on membership and community support activities
-
3,279 individuals in the free DEBRA membership scheme
-
71 weeks booked and enjoyed by 478 members in DEBRA’s six holiday homes
Looking to the future
We will continue to review plans postponed from 2020 and the changing needs of the EB community caused by the pandemic. We plan to increase engagement with our members. This will help shape care and support service developments and improve membership benefits with more regional/local events (virtual and hopefully in-person towards the second half of the year) providing greater opportunities for peer support and sharing information.
Life came to an abrupt end for me because of the virus. One day I was working, the next I was not able to go out due to my EB. I struggled to get food and my income suddenly stopped. I was scared and didn’t know what to do until Amelia called. Her support meant everything. She arranged a food parcel and helped me get financial support, I now feel mentally and physically much better.
Inderjeet, DEBRA Member
28
29
The first Covid-19 lockdown left Sharon needing a new focus, so she decided to give some of her time to volunteer at our store in Winstanley.
During the Covid-19 lockdown I was unable to work as a freelance children’s entertainer, actor and music researcher. I needed to do something productive and confidence boosting so, as soon as my favourite local DEBRA shop reopened, I signed up as a volunteer. I have learned many new skills, made new friends and enjoy serving customers. I like to get creative with shop displays. I get a real sense of achievement from volunteering.
Our retail stores
Our retail stores transform unwanted goods into funds for life-changing support and research to help our commitment to fighting EB. The pandemic had an enormous impact on our retail income in 2020. However, despite the challenging conditions faced by retailers in 2020, our sales performance after lockdown was more resilient than we expected, both in terms of sales and stock generation.
From a business perspective, the pandemic has been hugely disruptive, but there has been much to learn from the experience. The unexpected slowdown in our operations has given us the time and the motivation to accelerate our efforts to strengthen our portfolio, people and infrastructure, creating new opportunities and efficiencies in a rapidly changing world.
Key areas
Impact of the pandemic
As the scale of the COVID-19 outbreak became clear early in the financial year, we took the difficult but necessary decision to close all our retail outlets as of 22nd March 2020. Many of our colleagues, volunteers and supporters are in the high-risk category, and the safety of our people will always come first. With no retail income coming into the business due to successive lockdowns and to protect jobs in the long term, over 95% of retail colleagues were furloughed. Despite the welcome financial support from the UK Government, with a phased reopening of our shops and our small online operations starting in June, retail profit for 2020 was severely impacted. Gross retail income, including donations received in our stores and income from the Coronavirus Job Retention Scheme, decreased by £4.5m.
Restructure
The additional pressures on retail caused by the pandemic have meant that reducing operational overheads where possible has never been more important. As part of an internal review of operations, a limited restructure of the Retail Department was undertaken to merge the management structures of Traditional and Furniture & Electrical (F&E) stores. We have numerous examples of F&E stores being successfully managed through the Traditional management structure at DEBRA. The restructure gave us the opportunity to balance the workload across management teams, create greater service flexibility and align operational areas to maximise present and future efficiency. The restructure has proven extremely beneficial for the Retail Department and in support of our work.
Sustainability
We are working hard to develop a long-term sustainability plan and to significantly lower our carbon footprint. Our 109 charity shops help to prevent tonnes of textiles and furniture going to landfill each year. Alternatives to plastic for carriers are being trialled to reduce the number of single use plastic bags across our retail outlets.
Sharon Lowe, Volunteer DEBRA Winstanley
30
31
Estate
At the end of 2020, our portfolio consisted of 109 stores. The current portfolio is made up of four freeholds, 91 leaseholds and 14 temporary shops.
Significant partnerships
This year we have continued to grow our existing partnerships while trialling new partnerships and finding innovative ways of working with other brands. Moving forward, we plan to expand our online partnerships by working with various online pre-loved platforms to test selling our items to a younger audience, who are already engaged with shopping second-hand.
There will be a continued focus on developing our engagement and relationships with both corporate and local supporters to enhance the performance of DEBRA Retail and overall charity awareness.
Retail by numbers
-
109 shops at year end
-
£553,000 received through the Retail Gift Aid Scheme
-
Approximately 800 volunteers with almost 200 new volunteers signed up
Retail Gift Aid Scheme
In addition to the impact on trade this year, shop closures, social distancing and the need for contactless donations have also greatly impacted Gift Aid capture within stores across the country. Together with retail donations, this represented a total income of £606,000.
Our team
We continue to recognise the vital requirement for dedicated volunteers and staff and understand that our retail chain would not succeed without this support. We are continually looking to improve the experience of working and volunteering in our stores.
We know that in order to fight EB, we need a talented and ambitious community of people working in our stores and are focusing on key areas to make this happen. These areas include unlocking our people’s full potential, ensuring the provision of excellent training and induction programmes and a safe and trusted environment for all.
Our average volunteer numbers within Retail remain significantly lower than the sector average. The success of our stores depends greatly on our volunteers. Therefore in 2021 we will continue to place a strong emphasis on volunteer recruitment for our stores. We want to encourage people, with a diverse range of skills and backgrounds, to consider volunteering for us.
Looking to the future
The existing and unpredictable trading conditions have highlighted the need to maximise our organisational flexibility and to respond effectively and positively to changing circumstances.
We will continue to review our operating model and central costs to permit a more effective and efficient management of the Retail department, enabling us to focus on areas that generate the greatest level of contribution.
The lack of a mature e-Commerce operation is viewed as one of the key components affecting income performance when benchmarked with the sector.
Our retail aims for 2021
-
Continue the significant improvements in margin and contribution made before the pandemic with a strong focus on existing store optimisation and profitability.
-
Continue with the planned series of refurbishment projects within stores that we put on hold during 2020.
-
Ensure we have a stable and well-trained workforce and increase overall volunteer numbers.
-
Continue to invest in training for our shop teams, focusing on product and productivity while continuing to provide training and resource to ensure a safe retail environment for all staff and volunteers.
-
Deliver enhanced and structured training and induction programmes throughout all areas and consistent Health & Safety management and compliance across all stores.
-
Continue to identify and pursue cost savings which support bottom line growth, looking in particular at lease negotiations, distribution costs and facilities management.
-
Continue to work towards reducing the requirement for single-use plastic within our shops.
September 2020
DEBRA Patron HRH The Countess of Wessex volunteered at our newly opened store in Martins Heron, Bracknell, Berkshire to support the individuals and families living with EB.
The Countess volunteered alongside DEBRA volunteers and staff, and had a busy morning sorting donations, pricing stock and helping to serve customers.
32
33
Graeme Souness, our Vice President, united Scottish sports personalities under one roof for the Old Firm United to Fight EB event in March and helped to raise over £112,000 for vital research funding.
I am delighted to be Vice President because I am in a position to bring this charity to the attention of a number of people who will be able to make a real difference. I was appalled at just how cruel and painful the condition is – more people need to know about EB. If I can generate the sort of passion that I feel for this cause from a few people that I know then we could make a huge impact on the research into EB – research that not only will help those living with this now but could even lead to a cure.
Graeme Souness, DEBRA Vice President
How we raise our funds
Supporting the EB community
As a charity we are reliant upon our fundraising activities to deliver our charitable objectives. Everything people do to help support us – from hosting a fundraising event to donating directly – positively impacts the EB community. Our Fundraising Team strives to raise as much money as possible to help support our work and to fight EB. Those funds support our commitment to making a difference today through our healthcare and EB Community Support services, as well as working towards a better future through international collaboration and funding of pioneering research projects.
Our fundraising mission
Our traditional fundraising efforts include hosting a portfolio of high-quality major events as well as supporting individual fundraisers, applying to major trusts and grants and partnering with businesses for charity of the year status.
In 2020 we were unable to do much of what we had intended as our events programme was effectively put on hold by the pandemic in March. We are very thankful to our loyal supporters who responded to a series of appeals throughout the year to raise funds in support of our continued services to members.
Key areas
Trusts
We are grateful to the many grant making trusts that have supported us in 2020. These include the Patricia G. and Jonathan S. England Fund which has made a long term support commitment to DEBRA; the Peter Harrison Trust which has made a three-year commitment to supporting children with EB in the South East of England; the VTCT Foundation which has funded the changes to our website; the National Lottery Community Fund which funded all of our community support for three months during the height of the pandemic; and the Robert Luff Foundation which made a donation to support our research projects. There are many more whose support has been vital.
Major events
Thanks to the generosity of Michel Roux Jnr and the team at The Langham Hotel we were able to stage a successful Great Chefs Dinner in February. This was followed by a very successful Old Firm Dinner in March in Glasgow, with the generous support of our Vice President, Graeme Souness. Despite the difficult circumstances, our Events Team were able to run one more event, a Covid-secure shoot at E.J. Churchill Shooting Grounds in September.
Fundraising with the EB Community
We are very grateful to the number of people who took part in various challenges during the first lockdown of 2020 to raise funds for people with EB. Many of the EB community undertook their
34
35
own activities to raise money including sporting, walking and cycling challenges, while there was overwhelming support for the 2.6 Challenge that finished in May.
The DEBRA Golf Society
The Golf Team worked hard to ensure we were able to re-schedule and run 14 Covid-secure golf days in 2020. Numbers were limited due to social distancing and club restrictions but to realise a net income of over £77,000 was very impressive.
Appeals and legacies
The continued support of all who responded to our various appeals throughout the year was very positive. With so much of our fundraising being postponed we were reliant on donations. These included the Coronavirus Emergency Appeal in May, The Big Give and the Christmas Appeal featuring baby Ray in December. We also received multiple donations after a re-showing of the powerful documentary ‘The Boy Whose Skin Fell Off’ on Channel 4. We were also very fortunate to receive the support of a number of people who were kind enough to remember DEBRA in their wills.
Significant partnerships
We are extremely grateful to our Patron, HRH The Countess of Wessex, for her continued support throughout 2020 and to our President, Simon Weston CBE and Vice Presidents Frank Warren and Graeme Souness. We have also been fortunate to be able to count on the continued backing of a number of very generous supporters during these challenging times.
Our fundraising aims for 2021
-
Deliver a professional and profitable programme of events when it is safe to do so.
-
Utilise the events programme to progress relationships with major supporters, current corporate supporters and sponsors.
-
Work with our major supporters to leverage funds from their pledged support.
-
Empower people to continue to raise money for us and support those with a close connection to EB to raise funds in their local communities.
-
Raise awareness of the importance of legacies and the difference they make to enable us to support the EB community.
-
Invest in our Trust Application Team.
100km challengers
Amy Coote has EB Simplex and challenged herself to cycle 100 miles a day around Lincolnshire after the 2020 RideLondon event was cancelled due to COVID-19.
I have loved training to complete the event for DEBRA UK, even though the main RideLondon was cancelled. Cycling has now become a passion of mine for sure and it hasn’t affected my EB Simplex once.
Fundraising by numbers
-
£77,000 net income from the DEBRA Golf Society
-
£267,000 net income from individual donors
-
£444,000 net income from legacy and trust donations
-
£946,000 overall net fundraising income in 2020, compared with £1,671,000 in 2019
Looking to the future
The pandemic will continue to have a significant effect upon income generated for the charity in 2021. However, our experiences in 2020 have shown us that with a ‘can do’ attitude we can progress with events such as golf and shooting. We hope fundraising dinners will return in the last quarter and we have plans to put on some exciting events – especially with the support of our Vice Presidents. We have made considerable efforts to manage relations with key supporters closely over the last four years and this will stand us in good stead to recover from the lasting effects of the pandemic. We will continue to rely on the support and goodwill of our many supporters to help us get through this uncertain time.
Hannah West, who took on the 100km challenge went the extra mile and dyed her hair purple in support of DEBRA.
EB has a huge impact on my family. My eldest daughter Charlotte has the condition and not a day goes by when she doesn’t have a new injury to her skin which is really debilitating. The support DEBRA offers our family is outstanding. Through DEBRA, Charlotte has met other children with
EB and has made some firm friends who understand what she is experiencing day to day. We were really excited to participate as a family in the #FightEB 100km challenge. It’s wonderful to be able to show our appreciation to DEBRA and to raise awareness of this awful condition.
36
37
The worst thing about EB is the pain. The pain is incredible. I have to take so many painkillers every day – sometimes paracetamol and ibuprofen, sometimes the medication is so extreme it puts me to sleep. Then there’s the itch. Some days there is no itch at all and sometimes I have days where I just can’t stop itching. And there is normal stuff like eating. I can’t eat hard foods, like crisps, because that creates blisters in my mouth. The EB nurses are amazing. They know everything – without them, I probably wouldn’t know what to do with all the creams and dressings I have to put on every day to protect my skin. My skin scarring, the fusion of my fingers and the depletion of my skin tissue all increase as I get older which will make life even trickier for me.
I want to find a cure for EB if DEBRA hasn’t found one by the time I’m old enough to be a doctor. I have big plans. I want everyone to understand what having EB really means. We all need to be better educated.
Raising awareness
Public awareness of EB is low when benchmarked against conditions that have a similar number of people affected. A YouGov poll undertaken for DEBRA UK in 2020 revealed that 10% of UK adults surveyed had heard of EB. The level of awareness rose to 13% when given a description of EB. Conditions with similar numbers in the UK such as Motor Neurone Disease had a significantly higher level of awareness at 91%[1] .
Raising the awareness of EB, the profile of DEBRA and the work of the charity is a strategic priority within our five-year plan. We need to ensure all families living with EB have access to information, advice, support, advocacy, latest news and best practice. We need to ensure that the public are informed and engaged, creating greater understanding for those living with the condition, more widespread EB expertise and support for our income generation to enable us to fund vital research and care.
Key areas
Engagement
Our priority during the pandemic was to continue to connect with our community providing frequent information, advice and support and to support income generation to engage with our current supporter base and raise awareness for the gradual reopening of our retail stores.
Communication with our audiences quadrupled and media activity increased with the introduction of a new PR & Content role. We achieved a significant increase year on year in reach and engagement on social media and website traffic through additional digital expertise, more engaging content, focused messaging and specific campaigns targeting the EB community, healthcare, volunteers, retail and the general public.
We introduced new online campaigns to recruit volunteers, reach supporters and generate an increase in stock donations for the charity shops. The trial of a new digital initiative was launched to build a community of brand advocates, connecting with customers on local social media and putting the charity shops at the heart of their local community.
Raising awareness would not be possible without the help of the EB community and supporters who share their experiences of living with EB. Our EB Awareness Week campaign in October focused on a ‘back to basics’ approach with infographics and communications to explain ‘What is EB’ and sharing the emotive and inspirational personal illustrations of our EB ambassadors through ‘What is EB to me’ videos, blogs and social media posts. We reached over 1.1m people on social media through this effective, low-cost campaign.
Fazeel Irfan, living with RDEB
38
39
Digital and brand development
Through grant funding we were able to begin the development of a new website in quarter three – a critical factor in improving the positioning of the charity and the effectiveness of its online communications. Progress was delayed during lockdown while staff were on furlough.
A planned brand review project was also paused, but in the interim, we took the design refresh in-house, standardising branding and tone of voice throughout our publications and digital communications and revitalising messaging and signage across the retail stores.
Looking to the future
Since the charity was set up in 1978 it has become known for its commitment to investing in EB research, healthcare, support and best practice.
Our aim is to ensure we are recognised as the authority on EB knowledge and expertise and the source of information, advice, support, advocacy, latest news and best practice. We also want to achieve greater public awareness of EB to ensure there is understanding for those living with the condition, more widespread EB expertise and support for our income generation through fundraising and our retail stores to enable us to fund vital research and care. We need to ensure that we are a charity of choice for funders and that the public are informed and engaged enough to want to support us.
Awareness & engagement by numbers
-
Website: 1.2m page views, +20% year on year
-
Social Media: 5.2m organic reach, +295% year on year
-
DEBRA PR potential reach: 151.6m people
-
EB Awareness Week: 1.1m reach, +451% compared with weekly average
Our marketing aims for 2021
-
To raise awareness of EB and DEBRA, building a brand that is recognised by the EB community as the ‘go to’ source of support, expertise and information on EB and that resonates with the public as a charity of choice for funders and supporters.
-
Support income generation through increased awareness and engagement.
-
Increase understanding of EB and the specialist services and information DEBRA provides.
-
Improve access to information via multi-channel communications for all audiences at all touchpoints.
-
Create a digital-first offering for all external and internal audiences.
-
Build an engaged social community and an online presence that has credibility, is informative, provides access to expertise and latest knowledge and that is centred around the needs of the EB community.
1All figures, unless otherwise stated, are from YouGov Plc. Total sample size was 2,057 adults. Fieldwork was undertaken between 10th - 11th
November 2020. The survey was carried out online. The figures have been weighted and are representative of all UK adults (aged 18+)
40
41
Our people
From its origins, over 40 years ago, as a small support group for parents affected by EB, we have grown significantly – in income and personnel. At the end of 2020, DEBRA employed 360 staff and engaged approximately 800 volunteers. The range of jobs is broad, from managing a charity shop and organising fundraising events to processing income and supporting members with home visits, but each contributes significantly to the service that we provide to our membership.
Employees
The effects of the pandemic on our working practices were significant. The majority of office and administration staff worked from home, many staff were furloughed during the year and the safety and well-being of all of our people was more important than ever.
Communication during the pandemic was a priority. We communicated frequently with our staff and volunteers. This included regular e-newsletters, emails with updates about COVID-19, changes to working patterns such as furlough and a wide range of information about matters that affected them individually or as a whole.
During the year we worked with an external consultancy, People Puzzles, to consult with our employees and ensure their views were heard and incorporated into our strategic planning. The review included individual meetings, focus groups and surveys to understand our organisational culture and gain feedback on what working at DEBRA is like in difficult and turbulent times as well as taking the opportunity to drill down into specifics such as the onboarding process for our retail employees.
As a result of the employee feedback, we have launched some proactive projects that will underpin our ambition to be an “Employer of Choice” in the charity sector. These include a review of our benefits and recognition structure, updating our company values and launching a new Equality, Diversity & Inclusion framework.
Volunteers are a significant and highly valued resource for us. We rely on their commitment and dedication to enable us to undertake the work of our retail stores and support across many areas of the charity. Our Volunteer Manager worked closely with the Retail and Community Support Teams in 2020 to increase volunteer resources in these areas. The ‘EB Connections’ initiative, developed in 2019 and envisaging the development of Practical Community Volunteers (PCVs) to support members in their homes, was placed on hold due to the pandemic.
Learning and development
All members of staff are encouraged to continually develop their skills and the eLearning platform
42
43
first introduced in 2017 continues to prove useful, particularly in delivering mandatory training in Safeguarding, Equal Opportunities and GDPR.
In line with our Equal Opportunities policy, we take full and fair consideration of applications for employment made by disabled persons and their aptitude and abilities and encourage training, career development and promotion within our organisation.
Reflecting the increasing requirements to develop the skills of staff, and to develop bespoke training using technology such as eLearning modules, we recruited a dedicated Learning & Development Manager in February 2020. During the pandemic, bespoke training modules were developed for employees to complete while furloughed including training on the Retail Gift Aid Scheme.
Gender pay gap
A gender pay gap is a measure of the difference in the average pay of men and women, regardless of the nature of their work, across an entire organisation, business sector or the economy as a whole. Our mean hourly full pay gap is 2.61% in favour of males. As a comparison, our mean gender pay gap for 2019 was 4.9%.
The median hourly full pay gap is -2.39% in favour of the female workforce. The hourly pay analysis is based on 376 relevant full pay employees. The mean bonus pay gap is 4.92% in favour of females and the median bonus pay gap is -14.92% in favour of females. Bonus payment calculations relate to payments made to all eligible employees in the 12 months preceding the snapshot date.
The full Gender Pay Gap Report is available on our website.
Pay policy
Rates of pay and salaries within DEBRA are set at a level that are legally compliant and proportionate to the requirements of each role within the sector to attract and retain the best employees for each position. We benchmark key management and all pay rates to ensure we are competitive within the charity sector and in line with other trusted sources.
In January 2020, the annual pay review awarded a pay increase of 2% for all staff. In accordance with the Charity Statement of Recommended Practice, DEBRA discloses:
-
all payments to Trustees (no Trustees are paid) and reimbursed expenses
-
SMT (Senior Management Team) reimbursed expenses
-
the number of staff in receipt of £60,000 pa and above (in bands of £10,000)
-
employer pension contributions.
All aspects of pay – including rates, salary levels, reviews, incentive schemes and termination costs – were considered by the Quarterly Pay Review Committee, which reports to the Board of Trustees. In October 2020 QPRC was dissolved and has not been replaced. In order to maintain the required level of governance in relation to pay, a new process has been introduced whereby a business case must be put forward to the CEO for consideration before any kind of pay increase or change to incentives can be actioned. Where required Board approval will also be sought.
During March, April and May 2020, all of our employees were paid at 100% of their normal monthly salary. If employees were furloughed in these months, we topped up their furlough pay by 20%, i.e. from 80% to 100%, utilising the Government’s Coronavirus Job Retention Scheme. In June and July 2020, we enabled furloughed employees to take a week of annual leave at 100% pay to increase their monthly income. Between August and December 2020, we reduced furloughed employee pay to 80% with no top up.
Table 1: Summary Gender Pay Gap Report
Pay – hourly rate: the difference between men and women
| Mean | Median | |
|---|---|---|
| All | 11.31 | 8.98 |
| Female | 11.23 | 8.98 |
| Male | 11.53 | 8.77 |
| Pay Gap | 2.61 | -2.39 |
Table 2: Summary Gender Pay Gap Report
----- Start of picture text -----
Number receiving % Bonus
Mean bonus Median bonus
a bonus distribution
----- End of picture text -----
| Mean bonus | Median bonus | Number receiving a bonus |
% Bonus distribution |
|
|---|---|---|---|---|
| Female | 497.60 | 312.00 | 156 | 56.52 |
| Male | 474.25 | 271.50 | 46 | 46.00 |
| Pay Gap | -4.92 | -14.92 | - | - |
As part of our strategy to address the gender pay gap, we will be further developing our remuneration and benchmarking policies to move towards a more transparent and experience-based pay structure. In addition, we will continue to focus on the broader Equality, Diversity & Inclusion (EDI) agenda which will incorporate the activities and processes required to close our gender pay gap.
44
45
The coronavirus pandemic
Following the temporary closure of our charity shops in March 2020 and the postponement or cancellation of fundraising events, 85% of employees were furloughed in the same month. The remaining staff continued to work in their existing jobs or were redeployed to support DEBRA members, doing so from their homes. Since March, a further 8% of the workforce were furloughed. Supporting and maintaining regular communication with both these groups of employees became the focus for our Human Resources Team.
A phased opening of our charity shops started on 15th June 2020. Full PPE was provided to all stores and staff and all relevant government guidelines and measures were put in place for the safety of our staff, volunteers and customers. By late September 2020 all stores were open after a successful, phased re-opening. On 31st October 2020 the Government announced a second national lockdown resulting in the closure of all of our stores on 5th November 2020. We re-opened them on Wednesday 2nd December 2020. On 21st December 2020, the Government’s Tier System was introduced. Our shops were subsequently closed in the period leading up to Christmas and into early 2021.
Equal opportunities
We are at the beginning of creating an EDI strategy and development programme to make DEBRA a place where everyone is welcome and supported to achieve their potential. We are committed to developing a positive working environment that is not only free from discrimination, victimisation and harassment but is also one where people treat each other with mutual respect regardless of age, disability, gender, marital or civil partnership status, pregnancy and maternity, gender reassignment, race, religion and belief, sexual orientation, irrelevant offending background, responsibility for dependents, economic status or political values. The benefits that derive from having a diverse workforce are highly valued. In particular, the involvement of people affected by EB is actively sought in all aspects of the charity’s work.
Safeguarding and reporting of concerns
updated at three monthly intervals. The governance of the safeguarding provision is overseen by an experienced Trustee.
The Community Support Team received enhanced training in Level 2 Safeguarding and works closely with other agencies to ensure our members are safe and supported appropriately. Some members of the Community Support Team received further training in 2020 to take on the roles of ‘Designated Safeguarding Officers’ that report directly to the Safeguarding Lead in the organisation, with several safeguarding cases having been supported in the last 12 months.
In our retail stores, we are committed to creating a safe and rewarding environment in which all our people can work with a robust safeguarding policy to ensure everyone is treated properly. We also have a whistle blowing policy to ensure our staff can raise any concerns confidentially to a dedicated email address or by leaving a confidential message via a secure messaging facility.
All retail staff receive regular safeguarding training online and work closely with the designated Safeguarding Lead Officer to ensure that all staff, volunteers and customers are safe and supported appropriately. To ensure we are continually maintaining the highest standards of safeguarding, guidance from the Government, the Charity Commission and the Charity Retail Association on procedures and protocols for Safeguarding are monitored regularly. In the last 12 months, there have been several examples of robust action being taken to prevent harm to vulnerable people.
Working from home
In March 2020 our office-based employees had to adjust to new ways of working, which meant working from home due to office closures. Our management teams across the organisation established structured check-ins with the affected staff, provided several different types of communication technology including Zoom and Microsoft Teams, offered opportunities for remote social interaction within the team, developed resources for and awareness of the importance of mental health and well-being and provided encouragement and emotional support.
Safeguarding remains a priority within DEBRA, ensuring that any vulnerable person who comes into contact with DEBRA is adequately protected. All staff undertake mandatory training in safeguarding and in 2020 ‘Safeguarding September’ was introduced to maintain a high awareness of safeguarding among staff. ‘Safeguarding September’ also reminded employees and volunteers that any concern could be reported internally in confidence. Updated posters and alert cards were issued during this month. The Safeguarding Review group met quarterly in 2020 to review the safeguarding alerts that had been internally reported and to ensure that the appropriate action had been taken in each case.
The Designated Safeguarding Lead receives annual updated training via an accredited external training provider and attends an annual safeguarding conference. Other staff receive safeguarding training appropriate to their role. Policies and procedures relating to safeguarding are reviewed and, if necessary,
46
47
Financial review
Our accounts show the financial affairs of the charity for the year ended 31st December 2020. Net income after accounting for the costs of raising funds was £477k, dropping significantly from £3,905k achieved in 2019. Net income includes £1,249k received from the Coronavirus Job Retention Scheme and £824k from COVID-related local authority grants.
We entered the pandemic with strong reserves which enabled us to continue, enhance and adapt our charitable activities at this particularly difficult time for the EB community, despite the huge drop in income. We spent £2,848k on charitable activities in 2020, compared with £3,110k in 2019.
We have a large suite of charity shops which meant the pandemic hit us particularly hard. All shops were shut for four to six months of the year, which, despite government support, resulted in a deficit from the retail operation of (£673k), compared with £2,123k surplus achieved in 2019.
Many of our fundraising activities were severely curtailed during the year. Encouragingly our donor development programmes produced significant growth in this area. Overall net fundraising income was £946k in 2020, compared with £1,671k in 2019.
The deficit in the year was (£2,371k), funded by the historic build-up of reserves.
Charitable spend
Charitable spend in 2020 fell by just 8% over 2019. Research spend during 2020 was £1,181k (2019: £1,496k), whereas £839k (2019: £925k) was spent on Community Support initiatives, £347k (2019: £357k) on Healthcare services and £480k (2019: £333k) on Public Education.
48
49
Chart 1: Charitable Expenditure 2020
Table 3 Financial Summary £’000
The deficit in the year led to a decrease in net assets from £5,352k to £2,981k. There was £2,138k in the general fund, £766k in designated funds and £77k in restricted funds.
Summary
Table 3 summarises the highlights of our financial performance over the last five years. Gross income was £11,413k in 2020, a decline of £5,385k (32%) from 2019. Excluding government support of £2,073k the decline was £7,458k (44%).
Non-trading gross income was £4,387k, an increase of £912k over 2019, but excluding government financial support of £2,073k the figure would be £2,314k, a drop of £1,161k (33%) as a result of reduced corporate support and trust donations, and a significantly reduced calendar of community events,
Net retail income achieved through the shops (including Retail Gift Aid, commission and donations received in the shops) had grown dramatically between 2016 and 2019 from £1,318k to £2,123k. Despite government support of £1,916k attributable to retail, this fell to (£673k) in 2020.
See next page for Table 3 Financial Summary.
----- Start of picture text -----
2020 2019 2018 2017 2016
----- End of picture text -----
| 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|
| Gross income Non-trading income including all government support Net trading income Net retail income including government pandemic support, retail gift aid, commission and donations in shops Non-trading fundraising costs Charitable expenditure Retained surplus/(defcit) Retained surplus/(defcit) as a % of income Net current assets Unrestricted reserves Grantspayable within 1year |
11,413 4,387 (3,201) (673) 708 2,848 (2,371) (21%) 2,684 2,904 2,159 |
16,798 3,475 1,198 2,123 768 3,110 795 5% 4,878 5,138 2,201 |
16,138 2,979 1,193 2,138 727 2,966 479 3% 4,394 4,420 1,825 |
16,182 3,468 616 1,652 1,083 3,299 (299) (1.8%) 3,951 3,997 1,156 |
14,136 2,832 330 1,318 819 1,715 628 4.4% 3,340 4,301 1,519 |
The pandemic has had a devastating impact on our finances but, due to sound financial management in previous years, the strong reserves base was accessed to maintain close to normal levels of charitable activities.
The charity’s fixed assets comprise the premises and equipment required to operate trading activities; premises, furniture and equipment required to operate the charity’s offices; and five holiday homes held for the use of those affected by EB. The rest of the charity’s assets are held to promote the purposes of the charity through its support services and research programmes.
Reserves policy
DEBRA holds reserves to ensure the charity is able to continue supporting its beneficiaries and as a buffer for short term cash flow needs.
The Trustees’ reserves policy in 2020 was to maintain minimum cash-backed free undesignated reserves at £1,300k, plus a £250k balance in the designated fund for nursing continuity, to which the charity adhered. We have a high proportion of retail income, which usually provides a stable and reliable income stream. However, this incurs a high cost base, and the minimum reserves figure would cover one month’s costs (excluding rent) plus six months’ rent.
In a normal year, the charity’s income is to some extent dependent on a few large fundraising events at specific times in the financial year, as well as seasonal variations in the trading performance of the shops.
50
51
The Trustees conducted a thorough review of the reserves policy at the end of 2020, reviewing performance criteria in the light of the pandemic. Recognising the impact of a large drop in income as we experienced in 2020, the aim is to grow accessible reserves over the next 5 years to £3m. This would be sufficient to ensure a continuation of care services for at least 3 years.
Prior to the pandemic, the charity took the view that this was best achieved by investing funds not immediately needed in short-term money market deposits through Lloyds Bank Corporate Markets. The investments have been transferred to cash at the current time during this period of uncertainty.
Programme related investment
Total reserves at the end of 2020 were £2,981k, including £77k in restricted funds. Cash-backed free reserves before designations were £2,066k, of which £766k was designated for specific purposes, bringing the total cash-backed free reserves after designations to £1,300k. Cash-backed free reserves are calculated by subtracting fixed assets from unrestricted reserves and adding back 50% of unrestricted freehold and long leasehold property. This is the value that could be readily mortgaged, thus representing reserves that can be accessed relatively quickly.
Future Research Fund
A total of £516k was available in the designated fund for future research, which is in line with the charitable objectives of DEBRA and is anticipated to be spent or undesignated in the next year.
Nursing Continuity Fund
The amount of £250k was made available in the designated fund for nursing continuity. The purpose of this fund is to cover the cost of the continued nursing service to the EB community for six months in the event of the NHS withdrawing current levels of support. It is expected this fund will be spent in the next 5-10 years.
EB2020 Fund
The Trustees established a designated fund for the EB2020 World Congress which was hosted by DEBRA in January 2020 in London. There was a balance of £38k in this fund at the beginning of 2020, which has now been spent.
General Fund
There was £2,138k in the general fund, of which £1,078k can only be realised by disposing of tangible fixed assets. The Trustees are satisfied that there are sufficient cash balances to meet legal commitments as they fall due.
Investment policy
Trustees are authorised under the Articles of Association to invest any monies not immediately required for its objects in or upon such investments, securities or properties as may be thought fit.
The Trustees invested $250k (£191k) in the US biotech, FIBRX Derm, Inc, purchasing 203,252 series A-2 convertible preferred stock at a price of $1.23 per share. The purpose of this investment was in furtherance of the charitable objectives of the charity and no financial return is expected. The investment was made as part of our policy to invest in top quality, world class research. This will further our charitable objectives by supporting the development of a new treatment to help wound healing in patients suffering from Dystrophic EB.
The Trustees agreed to prudently impair this programme related investment by 99.99% in 2020 because the project has progressed well and the funds have substantially been spent. To all intents and purposes this investment was a research grant and the high impairment in the year reflects this fact.
Expenses policy
We have expenses policies for both staff and Trustees and a PAYE dispensation in place. Expenses that have necessarily been incurred by staff and Trustees in performance of their duties are recoverable from DEBRA. Expenses will only be reimbursed if they meet the following criteria:
-
no personal benefit could be derived from the expenditure by the employee concerned
-
the expenditure is reasonable and represents only additional costs to those that would normally arise on a personal basis
-
there is a clear charity justification for the costs
-
the expenditure does not represent a form of payment to a third party for work undertaken on our behalf.
Any expenses that do not meet the criteria above are regarded as a benefit by HMRC and as a matter of policy we do not reimburse such expenses.
Funds
The majority of our funds are unrestricted in application and are held in a general and two designated funds. Where funds are received that are restricted in their application to specific purposes or activities, these are held in a restricted fund. Details of restricted funds and designated funds are set out in Note 17 of the Financial Statements.
We aim to apply our income in support of our charitable objectives, and further investment is considered as an interim measure in respect of as yet uncommitted cash surpluses. All investment activities involve risk and reward, and the policy is to achieve a satisfactory return whilst minimising risk.
52
53
Asset cover for funds
Note 18 sets out an analysis of the assets attributable to the various funds. These assets are sufficient to meet the charity’s obligations on a fund-by-fund basis.
Related parties
DEBRA has a 100% beneficial interest in DEBRA Trading Ltd, whose principal activities in 2020 were a house clearance service and sales of new goods in our charity shops. Other activities include miscellaneous non-primary purpose trading undertaken by the charity. For information, the company’s results are shown separately in Note 22 of the Financial Statements.
Internal financial controls
The Trustees have conducted a review of the effectiveness of the charity’s internal financial controls in 2020, using the Charity Commission financial controls checklist. This review concludes that the controls are relevant, appropriate to DEBRA and are not too onerous or disproportionate.
The physical symptoms of EB are obvious to people but the emotional and psychological trauma you feel are just as painful. The constant itch drives me mad, and in my sleep I would tear and blister my skin constantly. My skin feels like it’s always on fire.
I was introduced to DEBRA in 1996 after I had been referred to the St Thomas specialist EB unit. The support DEBRA has given me has changed my life. I am now in regular contact with other people who have EB and I receive so much information and support to help with my everyday life. I should have asked for help a lot sooner but I thought I could cope on my own and I wasn’t aware of the support services available to the EB community. I have recently been given a care package and I now have a dedicated carer who visits me twice a day to do my dressings. I’m not suffering in silence anymore. When I speed off on the bike it’s like I leave EB in the gutter. After I have a day on my bike I need several to help my skin recover. But it is worth it. Life with EB is an unimaginable roller coaster and it has had a profound and devastating impact on my life. But I will not let EB beat me.
Les Paine, living with Dystrophic EB (DEB)
54
55
Table 4: Summary Extract from DEBRA’s Risk Register
Principal risks and uncertainties
The Trustees have established a register for all identified major strategic, business and operational risks identified by them to which the charity is exposed and confirm that these have been reviewed regularly during the year by the Finance, Risk and Audit Committee (as well as annually by the Board of Trustees) and that systems and procedures have been established to manage these risks. The initial responsibility for managing risk lies with the executive, prior to review by the Trustees.
A summary extract of the higher risks from our risk register is listed in Table 4 below, including the countermeasures (actions in place to reduce likelihood of the risk) and assurances (how the effectiveness of the countermeasures is determined). DEBRA as an organisation is very proactive in its management of risk, instilling a culture of recognition, ownership and tolerance level for each risk identified.
See next page for Table 4: Summary Extract from DEBRA’s Risk Register
----- Start of picture text -----
Countermeasure Assurance
Identified Risk Factor
----- End of picture text -----
| Identifed Risk Factor | Countermeasure | Assurance |
|---|---|---|
| Global pandemic causes UK-wide lock-down, threatening the going concern of the charity |
Access all forms of government funding, Coronavirus Job Retention Scheme, local authority retail grants, and the National Lottery Community Fund Cancel future expenditure commitments Home working to facilitate social distancing Risk assessments in shops Home working risk assessments Health and safety shop re- opening procedures |
Weekly Trustee Steering Group meeting Weekly Senior Management Team meetings Regular executive reporting to trustees Clear roles and responsibilities of trustees and staff identifed Appropriate reporting lines established Reverse stress testing to estimate when liquidity would break Financial forecasting including recovery planning following the COVID-19 pandemic through to end 2022 |
| Charity image damaged | Marketing and PR strategy Disciplinary policy Crisis communications plan Review of any complaints received Extensive social media policy for staff |
Media monitoring Annual staff appraisals Register of crises Investigation of occurrences |
| Insuffciently robust cyber security |
Anti-virus software Cyber insurance policy Encryption of hard drives Secured Wi-Fi connection Daily backups stored in the cloud Upgrade of frewalls PCI compliance Use of complex passwords |
Anti-virus tool displays Monthly reports Firewall logs checked regularly Daily logs of server activity |
| Misuse of data and failure to comply with Data Protection legislation |
In-house Data Protection Offcer External data protection consultancy Data protection policy Regular dataprotection training |
Data protection working party Regular reporting GDPR eLearning module |
| Loss of major source of income |
Diversity of fundraising activities Regular contact with key supporters Review of management information |
Regular reporting Review of key relationships Development of CRM database |
56
57
Going concern statement
The Trustees have reviewed the financial statements and forecast to the end of 2022, detailing the plans for financial recovery whilst maintaining a first-class service to the EB community. It is recognised that there are underlying uncertainties, however the Trustees consider the charity can continue its businesscritical activities and remain a going concern. The retail estate re-opened during April 2021 providing a regular income stream of unrestricted funds, plus the suite of fundraising events started up again. An analysis of risks and opportunities relating to the forecast resulted in net opportunities exceeding £400k, therefore uncertainties are expected to be managed and not be material to our ability to continue operating.
During the first few months of 2021 the third national lockdown impacted DEBRA’s financial situation, resulting in an estimated £2.1m reduction in total income following three-four further months of shop closures in early 2021. In addition, lockdown prevented face-to-face fundraising events taking place. The economic fallout of lockdown and the uncertainty it generated impaired the ability of individuals, corporate and trusts to make donations.
The Trustees therefore decided to carry out some cost reductions to mitigate this impact with further cost saving levers that could be pulled if required. This included the furlough of staff who are not involved in business-critical work, recruitment freeze and limited new research commitments. This has produced savings of £1.7m in 2021 compared with the original budget.
Before the pandemic struck DEBRA had financial strength with high cash balances which have provided a buffer to weather the storm. All applicable sources of government financial aid have been accessed. Given DEBRA’s financial strength at the outset of the pandemic, whilst uncertainty continues to exist, this does not pose a material uncertainty that would cast doubt on the charity’s ability to continue as a going concern. As the country emerges from lockdown, the financial plan demonstrates DEBRA will pull through this crisis and the Trustees consider it is still appropriate to prepare the 2020 accounts on a going concern basis.
58
59
Structure, governance & management
DEBRA (Company Limited by Guarantee) is a membership organisation and governed by its Articles of Association, which state that the Board of Trustees shall comprise of up to 15 Trustees, with no less than 50% of the Trustees having direct experience of EB management.
DEBRA Trustees
Our Board of Trustees is made up from a majority of those who have a direct experience of EB, who either have EB themselves or have a close family member with EB, and those who have skills and experience that will add value to the governance and leadership of DEBRA. Of the 15 Trustees, up to eight are elected by the membership and up to seven appointed by the Board. This ensures a good mix of skills, talents and experience to serve the DEBRA community.
No Annual General Meeting was held during 2020 due to the pandemic. The Board of Trustees reappointed Simon Cuzner for a further three-year term. The Board also co-opted Becky Edwards and Vivien Mundy who are both Elected Trustees for a second three-year term.
Two new candidates, Douglas Rouse and Michael Thomas, were also co-opted by the Board as Elected Trustees. James Hinchcliffe and Simone Bunting reached the end of their third term, so stepped down and David Wilkinson retired at the start of the year. The Trustees thank them for their valuable contribution to DEBRA over the last nine years. Following this, a postal vote of members took place which confirmed the co-opted appointments as Elected Trustees.
manage the shops, deliver operational performance against plan, comply with regulations and promote the cause of the charity.
Fundraising & Communications Committee – oversees the fundraising activities of the SMT on matters relating to the growth of income generation and maximising opportunities within Marketing and PR. The Committee approves and recommends to the Board of Trustees the strategic direction of fundraising and the financial plan. It utilises specific knowledge of its members to challenge and support the Director of Fundraising and Communications and the Marketing and PR Team to deliver against plans, comply with regulations and promote the cause of the charity.
DEBRA UK International Committee – determines and advises the Board of Trustees on matters relating to international strategy in research, healthcare, community support and international policy as the Board of Trustees may remit to it. In addition, the international Medical and Scientific Advisory Panel makes recommendations for research projects to DEBRA International which may be considered by the DEBRA UK International Committee.
Nominations & Governance Committee – oversees the structure, composition and effectiveness of the charity’s Board of Trustees and its Committees, as well as the appointment process of trustees. The Committee monitors the governance procedures of the charity.
Steering Group – this committee was created in light of the pandemic and meets regularly on an ‘as needed’ basis.
See Table 5 below – Trustees’ membership and attendance.
New Trustees receive a Trustee Handbook and other relevant publications, individual inductions from senior Trustees as relevant and Trustees attend external training courses appropriate to their role on the Board of Trustees. There are four board meetings per year, which the CEO attends and Senior Management Team members attend as required.
Trustee Board committees
Finance, Risk & Audit Committee – determines and advises the Board of Trustees on matters relating to finance, risk and audit as the Board of Trustees may remit to it, in particular the sound financial management of the charity, its resources and assets.
Care & Research Committee – determines and advises the Board of Trustees on matters relating to strategy in research, healthcare, community support and policy as the Board of Trustees may remit to it.
Retail Committee – determines and advises the SMT and the Board of Trustees on matters relating to the shops. It utilises specific knowledge of its members to assist the CEO and Director of Retail to
The Trustees plan to undertake a full review of the existing committee structure during 2021.
Board diversity
To ensure that we have a well-balanced board, those with experience of living or working with EB are the majority, together with those Trustees who do not have EB experience but possess the relevant skills and knowledge. The Board members come from a variety of backgrounds, in order to bring different perspectives to discussions and enhance the Board’s decision-making process.
We follow the Equal Opportunities Policy in the selection of Board members, in the same way we do for staff recruitment. Membership of the Board is open to all members of DEBRA, irrespective of age, disability, gender, marital or civil partnership status, pregnancy and maternity, gender reassignment, race, religion and belief, sexual orientation, irrelevant offending background, responsibility for dependents, economic status or political values. Broader diversity of the Board will be reviewed in 2021 as part of DEBRA’s Equality, Diversity & Inclusion project.
60
61
Charity governance code
The Board consistently reviews all aspects of DEBRA’s governance and ensures that our governance standards and practices fully embrace the principles of the Charity Commission ‘Charity Governance Code’. We are currently reviewing the updates to the code in December 2020, which strengthened the Principle of Equality of opportunity, Diversity and Inclusion (EDI) and updated the Integrity Principle.
Succession planning
We have built strength and depth in our Trustee Board, incorporating appropriate succession planning by appointing two Vice Chairs, each for periods of two years with an annual rotation of one of those. Prospective new trustees are often invited to join a committee for a minimum period of twelve months before becoming trustees.
-
we are a member of the Fundraising Regulator and comply with the relevant codes of practice
-
we received no fundraising complaints in 2020. We received 73 compliments in 2020 for either the service we provide to the EB Community or through liaising with the general public in DEBRA shops.
Activities in Scotland
We are active across several areas in Scotland. The primary charitable activities are seen in funding community support and research projects, notably at the Universities of Dundee and Edinburgh and the Cancer Research UK Beatson Institute, University of Glasgow. On the income generation side, there were two regional fundraising members of staff and 37 charity shops, both supported by an active volunteer network. The retail administration office for the entire charity is based in Blantyre.
Fundraising standards
Section 162a of the Charities Act 2011 requires charities to make a statement regarding fundraising activities. We do not undertake face-to-face fundraising from the general public. The legislation defines fundraising as ‘soliciting or otherwise procuring money or other property for charitable purposes’. Such amounts receivable is presented in the accounts as ‘voluntary income’ and include legacies and grants.
We make all efforts to train staff and ensure compliance with fundraising standards at all times. Specifically:
-
the majority of solicitations are managed internally, without involvement of professional fundraisers. The day-to-day management of all income generation is delegated to the executive team, who are accountable to the Trustees
-
where we work with third parties collaboratively on events or other activities, the charity has a contract in place to ensure standards are met
-
there are documented procedures in place for the management of fundraising products – such as collection boxes, public collections, online fundraising sites, etc
-
where volunteers assist in our fundraising activities, they are briefed verbally and/or in writing on the process and best practices and two-way partnerships are issued
-
volunteer fundraisers are managed and supported from the offices in Bracknell and Blantyre. Their progress is closely tracked, and they are advised of the standards expected of them
-
data protection procedures are in place governing the management of supporter and donor data on our DEBRA database; compliance with the GDPR rules that came into force in May 2018 continues to be monitored
-
we work with vulnerable people, particularly within the EB community, and often they wish to get involved with fundraising. There is close liaison between Fundraising and the Community Support Teams to identify any potential risks and act accordingly
62
63
Table 5: Trustees’ membership and attendance records as at 31.12.2020.
----- Start of picture text -----
Nominations Fundraising & DEBRA UK
Finance, Risk & Care & Research
Name Notes Board Attendance & Governance Retail Committee Communications International
Audit Committee Committee
Committee Committee Committee
----- End of picture text -----
| Name | Notes | Board Attendance | Finance, Risk & Audit Committee |
Nominations & Governance Committee |
Care & Research Committee |
Retail Committee | Fundraising & Communications Committee |
DEBRA UK International Committee |
|---|---|---|---|---|---|---|---|---|
| Jim Irvine | Chair | 7 of 7 | 5 of 5 | 5 of 5 | ||||
| David Bendor-Samuel | 6 of 7 | 5 of 5 | ||||||
| Simone Bunting | stood down 22.07.2020 |
2 of 3 | 4 of 5 | 6 of 6 | ||||
| Rebecca Cresswell | 4 of 7 | 5 of 6 | ||||||
| Simon Cuzner | 5 of 7 | 3 of 5 | 5 of 5 | |||||
| Carly Fields | 7 of 7 | 3 of 3 | 5 of 6 | |||||
| Andrew Grist | on leave of absence | 1 of 7 | 1 of 5 | 1 of 2 | ||||
| James Hinchcliffe | stood down 26.06.2020 |
leave of absence | ||||||
| Christo Kapourani | 4 of 7 | 1 of 3 | ||||||
| Graham Marsden | 5 of 7 | 5 of 5 | 1 of 1 | |||||
| Joanne Merchant | Treasurer | 7 of 7 | 5 of 5 | 5 of 5 | 1 of 1 | |||
| Vivien Mundy | 6 of 7 | 2 of 3 | 1 of 1 | |||||
| Timothy Powell | 5 of 7 | 3 of 3 | ||||||
| Douglas Rouse | elected 01.07.2020 | 3 of 4 | 5 of 5 | 1 of 1 | ||||
| Michael Thomas | elected 01.07.2020 | 3 of 4 | 2 of 3 | |||||
| David Wilkinson | stood down 23.01.2020 |
0 of 1 |
The committee chairs’ attendance is highlighted in bold.
64
65
Auditor
Trustees have taken all reasonable steps to make themselves aware of any information needed by the company’s auditor for the purposes of their audit and to establish that the auditor is aware of that information. The Trustees are not aware of any relevant audit information of which the auditor is unaware.
We engaged Sayer Vincent LLP as auditor during 2020 and they have expressed their willingness to continue in office. Under the Companies Act 2006 section 487(2) they will be automatically re-appointed as auditor 28 days after these accounts are sent to the members, unless the members exercise their rights under the Companies Act 2006 to prevent their re-appointment.
The Trustees’ Annual Report, incorporating the Strategic Report, is approved by the Board of Trustees and signed on behalf of the Trustees:
Jim Irvine
Trustees’ statement of responsibilities
The Trustees (who are also directors of DEBRA for the purposes of company law) are responsible for preparing the Trustees’ Annual Report including the strategic report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the Trustees are required to:
-
select suitable accounting policies and then apply them consistently
-
observe the methods and principles in the Charities Statement of Recommended Practice (SORP)
-
make judgements and estimates that are reasonable and prudent
-
state whether applicable UK Accounting Standards and statements of recommended practice have been followed, subject to any material departures disclosed and explained in the financial statements
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in operation.
Chair of Trustees
29th April 2021
The Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
In so far as the Trustees are aware:
-
there is no relevant audit information of which the charitable company’s auditor is unaware
-
the Trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information.
The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions. Members of the charity guarantee to contribute an amount not exceeding £1 to the assets of the charity in the event of winding up. The total number of such guarantees at 31 December 2020 was 3,279 (2019: 3,111). The Trustees are members of the charity but this entitles them only to voting rights. The Trustees have no beneficial interest in the charity.
66
67
Auditor’s report
Independent auditor’s report to the members of DEBRA.
Opinion
We have audited the financial statements of DEBRA (the ‘charitable company’) for the year ended 31 December 2020 which comprise the Statement of Financial Activities, balance sheet, statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion, the financial statements:
-
give a true and fair view of the state of the charitable company’s affairs as at 31 December 2020 and of its incoming resources and application of resources, including its income and expenditure, for the year then ended
-
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice
-
have been prepared in accordance with the requirements of the Companies Act 2006, the Charities and Trustee Investment (Scotland) Act 2005 and regulation 8 of the Charities Accounts (Scotland) Regulations 2006 (as amended).
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the Financial Reporting Council’s Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the Trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on DEBRA’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.
Other information
The other information comprises the information included in the Trustees’ Annual Report, including the strategic report, other than the financial statements and our auditor’s report thereon. The Trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
-
the information given in the Trustees’ Annual Report, including the strategic report, for the financial year for which the financial statements are prepared is consistent with the financial statements; and
-
the Trustees’ Annual Report, including the strategic report, has been prepared in accordance with applicable legal requirements
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees’ Annual Report, including the strategic report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 and the Charities Accounts (Scotland) Regulations 2006 (as amended) require us to report to you if, in our opinion:
-
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
-
the financial statements are not in agreement with the accounting records and returns; or
-
certain disclosures of Trustees’ remuneration specified by law are not made; or
-
we have not received all the information and explanations we require for our audit.
68
69
Responsibilities of Trustees
As explained more fully in the statement of Trustees’ responsibilities set out in the Trustees’ Annual Report, the Trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the Trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.
of any instances of non-compliance
-
detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected, or alleged fraud
-
the internal controls established to mitigate risks related to fraud or non-compliance with laws and regulations.
-
we inspected the minutes of meetings of those charged with governance
-
we obtained an understanding of the legal and regulatory framework that the charity operates in, focusing on those laws and regulations that had a material effect on the financial statements or that had a fundamental effect on the operations of the charity from our professional and sector experience
-
we communicated applicable laws and regulations throughout the Audit Team and remained alert to any indications of non-compliance throughout the audit
-
we reviewed any reports made to regulators
Auditor’s responsibilities for the audit of the financial statements
We have been appointed as auditor under section 44(1)(c) of the Charities and Trustee Investment (Scotland) Act 2005 and under the Companies Act 2006 and report in accordance with regulations made under those Acts.
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud are set out below.
-
we reviewed the financial statement disclosures and tested these to supporting documentation to assess compliance with applicable laws and regulations
-
we performed analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud
-
in addressing the risk of fraud through management override of controls, we tested the appropriateness of journal entries and other adjustments, assessed whether the judgements made in making accounting estimates are indicative of a potential bias and tested significant transactions that are unusual or those outside the normal course of business.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.
Capability of the audit in detecting irregularities
In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, our procedures included the following:
-
we enquired of management and Finance, Audit and Risk committee, which included obtaining and reviewing supporting documentation, concerning the charity’s policies and procedures relating to:
-
identifying, evaluating, and complying with laws and regulations and whether they were aware
Use of our report
This report is made solely to the charitable company’s members as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006 and section 44(1)(c) of the Charities and Trustee Investment (Scotland) Act 2005. Our audit work has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to
70
71
anyone other than the charitable company and the charitable company’s members as a body, for our
audit work, for this report, or for the opinions we have formed.
Fleur Holden (Senior Statutory Auditor)
Date: 6 May 2021
for and on behalf of Sayer Vincent LLP, Statutory Auditor Invicta House, 108-114 Golden Lane, LONDON, EC1Y 0TL
Sayer Vincent LLP is eligible to act as auditor in terms of section 1212 of the Companies Act 2006
Financial statements For the year ended 31 December 2020
72
73
Statement of Financial Activities
Statement of Financial Activities including income and expenditure account for the year ended 31 December 2020.
----- Start of picture text -----
2020 2020 2020 2020 2019 2019 2019 2019
Unrestricted funds Designated funds Restricted funds Total Unrestricted funds Designated funds Restricted funds Total
----- End of picture text -----
| 2020 Unrestricted funds 2020 Designated funds 2020 Restricted funds 2020 Total 2019 Unrestricted funds 2019 Designated funds 2019 Restricted funds 2019 Total |
|
|---|---|
| Notes Income and endowments from: Donations and legacies 2 Charitable activities Other trading activities 3 Investments 4 Other Total Expenditure on: Raising funds 6 Charitable activities 6 Total Net income/(expenditure) Transfer between funds Net movement in funds Reconciliation of funds: Total funds brought forward Total funds carried forward |
£ £ £ £ £ £ £ £ 3,814,335 - 468,926 4,283,261 2,790,693 - 573,611 3,364,304 18,210 - - 18,210 20,299 - - 20,299 6,903,611 75,771 46,491 7,025,873 12,845,645 264,717 211,958 13,322,320 47,403 - - 47,403 56,544 - - 56,544 38,150 - - 38,150 34,432 - - 34,432 |
| 10,821,709 75,771 515,417 11,412,897 15,747,613 264,717 785,569 16,797,899 |
|
| 10,935,662 - - 10,935,662 12,891,642 - 1,000 12,892,642 1,452,433 821,551 573,782 2,847,766 1,446,033 1,141,627 522,388 3,110,048 |
|
| 12,388,095 821,551 573,782 13,783,428 14,337,675 1,141,627 523,388 16,002,690 |
|
| (1,566,386) (745,780) (58,365) (2,370,531) 1,409,938 (876,910) 262,181 795,209 1,473,695 (1,395,027) (78,668) - (1,170,160) 1,355,000 (184,840) - |
|
| (92,691) (2,140,807) (137,033) (2,370,531) 239,778 478,090 77,341 795,209 |
|
| 2,231,188 2,906,757 213,576 5,351,521 1,991,410 2,428,667 136,235 4,556,312 |
|
| 2,138,497 765,950 76,543 2,980,990 2,231,188 2,906,757 213,576 5,351,521 |
All operations are continuing. The Statement of Financial Activities also complies with the requirements for an income and expenditure account under the Companies Act 2006.
The notes on pages 79-106 form part of these financial statements.
74
75
Balance sheet
Balance sheet as at 31 December 2020.
----- Start of picture text -----
2020 2019
----- End of picture text -----
| Notes Fixed assets Tangible assets 10 Programme related investment 11 Investment in DEBRA Trading Ltd 22 Current assets Current asset investment 12 Stocks Debtors 13 Cash at bank and in hand Fixed assets held for sale Creditors: amounts falling due within one year 14 Net current assets Total assets less current liabilities Creditors: amounts falling due over one year 14 Provisions for liabilities Total net assets |
£ - 5,910 1,616,619 5,076,553 167,960 |
£ 1,077,946 1 2 |
£ 3,750,000 6,300 1,926,703 2,898,199 78,000 |
£ 1,262,260 - 2 |
|---|---|---|---|---|
| 1,077,949 | 1,262,262 | |||
2,684,323 |
4,878,022 | |||
| 6,867,042 | 8,659,202 | |||
| (4,182,719) | (3,781,180) | |||
| 3,762,272 (599,474) (181,808) |
6,140,284 (546,951) (241,812) |
|||
| 2,980,990 | 5,351,521 |
| The funds of the charity Restricted income funds 16 Unrestricted funds 17 Total charity funds Unrestricted funds - Designated 17 - General Restricted funds 16 Total charity funds Company registration number 4118259 |
76,543 2,904,447 2,980,990 765,950 2,138,497 2,904,447 76,543 2,980,990 |
213,576 5,137,945 |
|---|---|---|
| 5,351,521 | ||
| 2,906,757 2,231,188 |
||
| 5,137,945 213,576 |
||
| 5,351,521 | ||
The accounts were approved by the Board on 29th April 2021 and signed on their behalf by:
J Irvine Jim Irvine Joanne Merchant Chair of Trustee Board Treasurer
76
77
Cash flow statement
Notes to the accounts
----- Start of picture text -----
2020 2019
----- End of picture text -----
| Notes £ Cashfows from operating activities: Net cash provided by operating activities 17 Cashfows from investing activities: Dividends, interest and rents from investments 47,403 Proceeds from the sale of property, plant and equipment 7,052 Purchase of property, plant and equipment (68,791) Proceeds from sale of investments 3,750,000 Purchase of investments (190,840) Net cash (used in) / provided by investing activities Change in cash and cash equivalents in the reporting period Cash and cash equivalents at the beginning of the reporting period Cash and cash equivalents at the end of the reporting period |
£ £ (1,366,471) 56,544 - (383,314) - (1,000,000) 3,544,825 2,178,354 2,898,199 5,076,553 |
£ 1,580,543 |
|---|---|---|
| (1,326,770) 253,773 2,644,426 |
||
| 2,898,199 |
The notes on pages 79 to 106 form part of these financial statements.
1 Accounting policies
1.1 Basis of preparation
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015), Charities SORP (FRS 102) (second edition - October 2019), the Companies Act 2006, the Charities Accounts (Scotland) Regulations 2006 as amended and the Charities and Trustees Investment (Scotland) Act 2005.
1.2 Going concern
The Trustees reviewed the charity’s budget in December 2020 and were content that these plans were affordable and that the accounts should be prepared on going concern basis. However the continuing impact of the coronavirus pandemic and its effect has meant that the Senior Management Team and Trustees have been reviewing financial plans for the next 12 months to ensure the charity can continue its business-critical activities and remain a going concern.
The Government decision to impose a third national lockdown has had an effect on DEBRA’s financial situation, resulting in an estimated £2.1m reduction in total income following three-four further months of shop closures in 2021. In addition, on-going social distancing measures present challenges to running fundraising events. The economic fallout of lockdown and the uncertainty it generates impairs the ability of individuals, corporate and trusts to make donations.
The Trustees have, therefore, decided to carry out some cost reductions to mitigate this impact with further cost saving levers which can be pulled should it be required. This includes the furlough of staff who are not involved in business-critical work, recruitment freeze and limited new research commitments. This has produced savings of £1.7m in 2021 compared with the original budget. Before the pandemic struck DEBRA had financial strength with high cash balances which have provided a buffer to weather the storm. All applicable sources of government financial aid have been accessed.
Taking into account the measures announced by the government in the March 2021 budget, a financial forecast has been prepared to the end of 2022, detailing the plans for financial recovery whilst maintaining a first-class service to the EB community.
Given DEBRA’s financial strength at the outset of the pandemic, whilst uncertainty continues to exist, this does not pose a material uncertainty that would cast doubt on the charity’s ability to continue as
78
79
a going concern. As the country emerges from lockdown, the financial plan demonstrates DEBRA will pull through this crisis and the Trustees consider it is still appropriate to prepare the 2020 accounts on a going concern basis.
Claims made through the UK Government’s Coronavirus Job Retention Support Scheme are recognised as income in the period which the associated staff were furloughed. This income is considered to be unrestricted. Small business retail grants have been recognised as unrestricted income in the periods to which they relate.
1.3 Legal status of charity
The charity is a company limited by Guarantee and has no share capital. In the event of the charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the charity.
1.4 Judgements and estimates made by management
The financial statements include judgements and estimates as defined by the accounting policies. Legacy income is recognised as probable at probate, using an estimate provided by executors. Premises service charge liabilities are estimated from information supplied by property specialists. The dilapidations provision is reviewed annually on an individual lease basis by a property specialist. Research grants are recognised in full in the Income and Expenditure Account at the point of commitment in order to ensure no reliance on future fundraising to meet these financial commitments. Programme related investments are impaired based on a judgement of the intrinsic value of the investment at the balance sheet date, where no market value exists.
The Trustees do not consider that there are any sources of estimation uncertainty at the reporting date that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next reporting period.
1.5 Income
Donations and gifts are recognised in full in the Statement of Financial Activities when received. Unclaimed gift aid receivable is accrued in the year to which it relates. Legacies receivable are recognised when there is entitlement, probability of receipt and is measurable. Grants are recognised in full when received. Gifts in kind are only included in the accounts where the Trustees can ascribe a value in excess of £1,000.
Landlord concessions received during the COVID-19 pandemic have not been treated as gifts in kind because the Trustees considered due to the extent of the concessions as a result of the generosity of the landlords, it would significantly distort the accounts for the reader, therefore rent concessions are reflected as reductions in rent costs in the year.
Trading income is recognised in full when received with the exception of income that is deferred where it represents a payment in advance for a specific event that will not take place until a future accounting period. This exception does not apply to sponsorship for charity challenges taking place in a future accounting period.
1.6 Expenditure
Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs related to the category. Equipment purchased for use in research is written off as part of the research project costs as incurred. Expenditure on raising funds are those costs incurred in seeking voluntary contributions and running the retail operations. Charitable activities include expenditure associated with the operation of the charity and the provision of its services. Governance costs comprise the costs relating to the general running of the charity, and include direct items such as external audit, legal advice for trustees, the cost of trustee meetings, and are included in central overhead costs. Central costs are apportioned and allocated between the cost of raising funds and charitable expenditure on the basis of central staff time allocation to the various activities.
1.7 Recognition of grant liabilities
Grants are awarded for research projects over a period of one to five years. All grants provide the right to terminate with up to three months’ notice and continuation of funding is dependent on satisfactory progress reporting and review. It is always the intention to honour the funding of all grants awarded and full grant recognition has been incorporated into these accounts as the most appropriate and prudent policy. By adopting this policy, the Trustees ensure the funds for research grants have been raised in full prior to making financial commitments to research institutions.
1.8 Tangible fixed assets and depreciation
Tangible fixed assets with a value in excess of £1,000 are capitalised and stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:
| Freehold and long leasehold buildings | Over 25 years |
|---|---|
| Head offce ft out costs |
Over life of the lease |
| Mobile homes |
Over 10 years |
| Fixtures, fttings, static equipment | Over 5 years |
| Shop equipment |
Over 5 years |
| Motor vehicles |
Over 4 years |
| Mobile equipment |
Over 3 years |
A review of assets is undertaken annually, and adjustments are made to the expected useful life as required. From 1 January 2009 freehold land and buildings are assumed to have a residual value of 50%.
80
81
1.9 Sale and leaseback
In 2017 the charity sold office premises originally purchased in 2004. These premises were leased back at market rent, until January 2020.
1.10 Programme related investment and impairment
Programme related expenditure with a value in excess of £1,000 is stated at cost less impairment. The investment held in 2020 has been impaired by 99.99% in year one, with a residual holding value of £1.
1.11 Cash and short-term investments
The charity holds cash requirements for day-to-day activities in current bank accounts with HSBC, Lloyds, Santander and Clydesdale. The deposit account is held with HSBC. Short-term investments that were held in money market deposits with Lloyds Commercial Banking were redeemed early at the start of the coronavirus pandemic. For the purposes of the cash flow statement, cash equivalents are defined as current asset investments, and short-term deposits with a maturity of less than 3 months, which are readily convertible into known amounts of cash.
1.12 Debtors
Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
1.16 Accumulated funds
Restricted funds are subject to specific conditions by donors as to how they may be used. Transfers between unrestricted funds and designated funds occur when the Trustees approve either funds to be designated for a specific purpose, or where remaining designated funds are no longer required and are released to unrestricted funds. The exceptional circumstances of 2020 resulted in funds being undesignated in order for the charity to continue its charitable objectives. The purposes and uses of the restricted funds and designated funds are set out in Note 17 to the financial statements.
1.17 Consolidated accounts
The accounts of DEBRA Trading Limited and DEBRA Retail Limited have not been incorporated into these accounts on the grounds that the results are not material. The profit covenanted by DEBRA Trading Limited is included in other trading activities. DEBRA Retail Limited was dormant throughout the year. This report therefore provides information about the standalone charity only. For information, the company’s results and the investment the charity holds in DEBRA Trading Limited are shown separately in Note 22 to the financial statements.
1.18 Foreign currency translation
Foreign currency transactions are recorded at the exchange rate at the time of the transaction. Foreign currency assets and liabilities are translated into sterling at the exchange rate ruling at the balance sheet date. Resulting gains or losses on retranslation are included in the statement of financial activities.
1.13 Creditors
Trade creditors and other payables are normally recognised at their settlement amount after allowing for any trade discount due. Payments to suppliers are within standard payment terms of 30 days. Liabilities are recognised when there is a present obligation, as a result of past events, and there is a probable future outflow of resources that can be estimated reliably.
1.19. Leases
Operating lease annual rental payments are charged to the statement of financial activities on a straight line basis over the term of the lease.
1.20. Termination payments
1.14 Financial instruments
The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at settlement value.
Termination payments either by way of redundancy or settlement agreement are recognised at the time of payment. Any payments exceeding the statutory minimum are authorised by the Trustees.
1.15 Stock
The Trustees do not consider it appropriate to recognise donated goods for resale as stock on the grounds that the cost of obtaining stock information would greatly outweigh any benefit. The costs involved would include the setting up of processes and procedures for a stock count in over 100 shops, training shop staff and volunteers in the process, software programming, and the checking and analysis of the reports produced.
All other stock is valued at the lower of cost or net realisable value.
82
83
3 Other trading activities
2 Donations and legacies
----- Start of picture text -----
Unrestricted Restricted Total Total
funds funds 2020 2019
----- End of picture text -----
| Donations & gifts Legacies receivable Grants receivable Donations & gifts: Individual donations Corporate donations International donations Events by individuals Grants receivable: Charitable trusts Government grants |
£ £ £ £ 1,438,777 157,348 1,596,125 2,671,296 219,678 37,500 257,178 184,761 2,155,880 274,078 2,429,958 508,247 |
|---|---|
| 3,814,335 468,926 4,283,261 3,364,304 |
|
| 1,189,520 128,112 1,317,632 2,012,963 234,413 26,488 260,901 590,001 496 - 496 524 14,348 2,748 17,096 67,808 |
|
| 1,438,777 157,348 1,596,125 2,671,296 |
|
| 82,962 274,078 357,040 508,247 2,072,918 - 2,072,918 - |
|
| 2,155,880 274,078 2,429,958 508,247 |
Government grants consist of £1,248,868 (2019: 0) received under the Coronavirus Job Retention Scheme and £824,050 (2019: 0) received in local authority grants.
Gifts in kind of £88,006 (2019: £100,454) are included in donations and gifts. These include the ongoing advertising in a national newspaper valued at £20,800 (2019: £20,800) and online AdWords valued at £67,206 (2019: £70,308).
----- Start of picture text -----
Total Total
2020 2019
----- End of picture text -----
| 2020 2019 |
|
|---|---|
| Income Operating expenses Net income from fundraising activities |
£ £ 7,025,873 13,322,320 (10,227,464) (12,124,386) |
| (3,201,591) 1,197,934 |
The greatest income from other trading activities is derived from the operation of charity shops selling donated goods. As at 31 December 2020 there were 109 shops trading (2019:121). The major categories of income and expenditure are summarised below:
----- Start of picture text -----
Income Operating Net income Net income
expenses 2020 2019
----- End of picture text -----
| Income Operating expenses Net income 2020 Net income 2019 |
|
|---|---|
| Retail Fundraising events Miscellaneous trading |
£ £ £ £ 6,477,316 (9,757,368) (3,280,052) 751,975 429,761 (470,096) (40,335) 84,552 118,796 - 118,796 361,407 |
| 7,025,873 (10,227,464) (3,201,591) 1,197,934 |
Retail income excludes income of £606,091 (2019: £1,226,225) from retail Gift Aid and retail donations, which are recognised as donations on the SOFA and not income from other trading activities. Retail income also excludes retail gift aid commission of £84,619 (2019: £144,523) which is recognised in miscellaneous trading. In 2020 the COVID-19 pandemic had a significant impact on gross retail income, dropping by 47%. There was also a drop of 12 in the number of shops trading. The profit covenanted by DEBRA Trading Limited of £34,176 (2019: £216,884) is recognised in miscellaneous trading.
The table below reflects a true statement of total retail income, including retail Gift Aid, commission and retail donations.
84
85
----- Start of picture text -----
2020 2019
----- End of picture text -----
| £ | £ | |
|---|---|---|
| Retail income | 7,168,026 | 13,609,304 |
| Retail expenditure | (9,757,368) | (11,486,581) |
| Retail net income | (2,589,342) | 2,122,723 |
| Investment income | Total Unrestricted 2020 |
Total 2019 |
| Interest receivable Rent of property Total investment income |
£ £ 29,940 29,766 17,463 26,778 |
|
| 47,403 56,544 |
Rental income was received from one freehold shop and two flats situated above properties, which were acquired.
4 Investment income
----- Start of picture text -----
Total Unrestricted Total
2020 2019
----- End of picture text -----
| Interest receivable Rent of property Total investment income |
£ £ 29,940 29,766 17,463 26,778 |
|---|---|
| 47,403 56,544 |
5 Grants payable
Expenditure on charitable activities include grants payable to third parties as detailed in Note 21. There were 154 (2019: 334) Community Support grants totalling £38,071 (2019: £85,117) made through the Community Support programme. All other grants were payable to institutions as detailed in Note 21.
Routine Healthcare and Community Support work is considered on-going and for which no future commitment is provided. Research and clinical projects have a finite life and at 31 December 2020 the Trustees had authorised a commitment to support research grants over the next three years to the sum of £1,183,468 (2019: £1,428,243) and clinical projects to the sum of £138,105 (2019: £186,213).
The total future commitment is currently committed to be spent as follows:
| Total 2020 Total 2019 |
|
|---|---|
| Within 1 year Within 2-3 years Within 4-5 years Provided within the grants payable creditor (note 14) |
£ £ 722,099 1,067,505 589,406 489,658 10,068 57,293 |
| 1,321,573 1,614,456 |
|
| 1,321,573 1,614,456 |
Rental income was received from one freehold shop and two flats situated above properties, which were acquired in 2009.
86
87
6 Expenditure
----- Start of picture text -----
Staff Grants Other costs Total Total
costs payable 2020 2019
----- End of picture text -----
| Raising funds: Donations and legacies Other trading activities Charitable activities: Research Healthcare Community support Respite breaks Public education |
£ £ £ £ £ 415,507 - 292,691 708,198 768,256 5,703,336 - 4,524,128 10,227,464 12,124,386 6,118,843 - 4,816,819 10,935,662 12,892,642 |
|---|---|
| 339,024 572,731 269,343 1,181,098 1,495,647 80,880 241,967 23,990 346,837 357,350 651,422 38,072 56,432 745,926 824,070 - - 93,467 93,467 100,434 367,838 - 112,600 480,438 332,547 |
|
| 1,439,164 852,770 555,832 2,847,766 3,110,048 |
|
| 7,558,007 852,770 5,372,651 13,783,428 16,002,690 |
----- Start of picture text -----
Staff Grants Other costs Total Total
costs payable 2019 2018
----- End of picture text -----
| Raising funds: Donations and legacies Other trading activities Charitable activities: Research Healthcare Community support Respite breaks Public education |
£ £ £ £ £ 373,590 - 394,666 768,256 727,350 5,778,241 - 6,346,145 12,124,386 11,966,308 6,151,831 - 6,740,811 12,892,642 12,693,658 |
|---|---|
| 315,029 685,893 494,725 1,495,647 1,366,338 103,825 224,194 29,331 357,350 472,066 680,069 85,117 58,884 824,070 781,204 - - 100,434 100,434 84,674 224,927 - 107,620 332,547 261,382 |
|
| 1,323,850 995,204 790,994 3,110,048 2,965,664 |
|
| 7,475,681 995,204 7,531,805 16,002,690 15,659,322 |
88
89
Other costs
----- Start of picture text -----
Depreciation Overhead Miscellaneous Total Total
and allocation costs 2020 2019
amortisation
----- End of picture text -----
| Raising funds: Donations and legacies Other trading activities Charitable activities: Research Healthcare Community support Respite breaks Public education |
£ £ £ £ £ - 174,569 118,122 292,691 394,666 78,022 301,865 4,144,241 4,524,128 6,346,145 78,022 476,434 4,262,363 4,816,819 6,740,811 |
|---|---|
| - 38,798 230,545 269,343 494,725 - 23,990 - 23,990 29,331 - 56,432 - 56,432 58,884 48,016 - 45,451 93,467 100,434 - 43,441 69,159 112,600 107,620 |
|
| 48,016 162,661 345,155 555,832 790,994 |
|
| 126,038 639,095 4,607,518 5,372,651 7,531,805 |
----- Start of picture text -----
Depreciation Overhead Miscellaneous Total Total
and allocation costs 2019 2018
amortisation
----- End of picture text -----
| Raising funds: Donations and legacies Other trading activities Charitable activities: Research Healthcare Community support Respite breaks Public education |
£ £ £ £ £ - 178,750 215,916 394,666 383,899 83,116 292,446 5,970,583 6,346,145 6,347,696 83,116 471,196 6,186,499 6,740,811 6,731,595 |
|---|---|
| - 33,553 461,172 494,725 93,104 - 29,331 - 29,331 25,026 - 52,439 6,445 58,884 51,556 35,613 - 64,821 100,434 84,674 - 107,620 - 107,620 79,191 |
|
| 35,613 222,943 532,438 790,994 333,551 |
|
| 118,729 694,139 6,718,937 7,531,805 7,065,146 |
Net income / (expenditure) for the year is stated after charging:
----- Start of picture text -----
2020 2019
----- End of picture text -----
| Operating leases Auditors remuneration Non-audit services Depreciation of tangible fxed assets Defned contribution pension costs Exchange differences |
£ £ 1,279,426 1,639,888 19,313 20,420 - 24,773 158,451 138,758 345,016 312,098 (20,916) 34,441 |
|---|---|
90
91
7 Cost allocation
All central overhead costs are allocated to activities on the basis of staff time, and are detailed below:
| 2020 2019 |
|
|---|---|
| Staff costs: Overheads: Offce premises rent Service charges, utilities & cleaning Equipment costs Postage, printing, stationary, telephone & fax Insurance costs Legal, professional & consultancy fees Depreciation Irrecoverable VAT Bank charges Sundry expenses Governance costs: Audit fees Miscellaneous costs Total Allocation |
£ £ 1,521,167 1,450,761 62,891 58,640 57,788 54,644 148,634 142,517 54,502 82,430 97,435 92,458 135,198 50,278 36,829 22,653 24,216 52,988 6,755 15,081 - 8,681 87,224 19,313 20,420 4,215 14,806 |
| 639,095 694,139 |
|
| 2,160,262 2,144,900 |
8. Trustees
9 Employees
The average number of employees during the period was:
----- Start of picture text -----
2020 2020 2019
Full time equiv Number Number
----- End of picture text -----
| Research Healthcare Community Support Fundraising & Comms Retail Management & Administration At the end of the year the number of employees per department was: Research Healthcare Community Support Fundraising & Comms Retail Management & Administration |
2.9 5 5 - - 1 11.2 12 15 18.2 20 14 232.5 321 331 15.7 18 19 |
|---|---|
| 280.5 376 385 |
|
| 2020 Full time equiv 2020 Number 2019 Number 1.6 4 5 - - 1 9.7 10 17 17.2 19 14 221.6 304 332 14.2 16 19 |
|
| 264.3 353 388 |
*These numbers exclude healthcare staff funded through grants to external organisations as detailed in Note 19. Staff employed by external institutions and funded through research grants are also excluded.
None of the Trustees received any remuneration from DEBRA during the period, but nine of them were reimbursed a total of £2,259 (2019: 6 - £3,871) for travel, subsistence and training expenses.
Employment costs
Tim Powell’s wife received £600 (£2019: £1,400) for administrative services at EB2020. James Hinchcliffe received a community support grant totalling £0 (2019: £720). Andy Grist received community grants totalling £15 (2019: £528). The aggregate figure for trustee donations in 2020 was £2,158 (2019: £726). In addition many trustees have supported DEBRA by attending events.
Insurance has been purchased to protect DEBRA, its employees and trustees from professional and legal liability of trustees and employees in the event of a claim that arises from the actions of such persons acting in such capacity at a cost of £2,253 (2019: £1,883), as allowed under section 4.3.3 in DEBRA’s Articles of Association.
----- Start of picture text -----
Total Total
2020 2019
----- End of picture text -----
| 2020 | 2019 |
|
|---|---|---|
| Wages & salaries Social security costs Pension costs |
£ 6,484,221 432,918 345,016 |
£ 6,231,757 395,899 312,098 |
| 7,262,155 | 6,939,754 |
92
93
The charity does not operate any defined benefit pension scheme. The charity makes payments to certain employees’ personal pension plans. Payments of £313,959 (2019: £309,502) were made in the year and charged to the SOFA in the period they were due. At the year end there remained £24,016 (2019: £5,917) unpaid.
During the year the CEO and SMT were paid relevant business expenses totalling £13,028 (2019: £37,237).
The following members of staff received emoluments above £60,000:
----- Start of picture text -----
2020 2019
----- End of picture text -----
| Between £60,001 - £70,000 | 3 | 2 |
|---|---|---|
| Between £80,001 - £90,000 | 2 | 2 |
| Between £100,000 - £110,000 | 1 | - |
| Between £140,001 - £150,000 | - | 1 |
The figures above exclude a compensation payment made to the ex-CEO of the charity. If this compensation figure is included there would be one member of staff who received emoluments between £170,000 and £180,000.
Redundancy and compensation payments totalled £124,289 in 2020 (2019: £12,195), which were all paid in 2020.
The aggregate pay of key management personnel, including employer’s NI and pension contributions was £736,268 (2019: £678,512). The aggregate employer’s pension contribution for key management personnel was £59,304 (2019: £70,856)
In respect of the above employees, contributions for the year into a defined contribution pension scheme totalled £53,426 (2019: £62,666), and there are retirement benefits accruing for six (2019: five) employees under a defined contribution scheme.
10 Fixed assets
Tangible fixed assets
----- Start of picture text -----
Shop Mobile Fixtures, Freehold Long Total
equipment homes fittings & land and leasehold
equipment buildings land and
buildings
----- End of picture text -----
| Cost: At 1 January 2020 Transfer to current assets Additions Disposals At 31 December 2020 Depreciation: At 1 January 2020 Transfer to current assets Charge for the year Disposals At 31 December 2020 Net Book Value: Brought forward At 31 December 2020 |
£ £ £ £ £ £ 403,961 547,162 325,614 699,347 82,500 2,058,584 (121,000) (121,000) 36,245 - 32,546 - - 68,791 (2,464) (67,000) (37,042) - - (106,506) |
|---|---|
| 437,742 480,162 321,118 578,347 82,500 1,899,869 228,065 216,582 165,240 168,287 18,150 796,324 (26,620) (26,620) 59,075 48,017 36,829 12,881 1,650 158,452 (2,191) (67,000) (37,042) - - (106,233) |
|
| 284,949 197,599 165,027 154,548 19,800 821,923 175,896 330,580 160,374 531,060 64,350 1,262,260 |
|
| 152,793 282,563 156,091 423,799 62,700 1,077,946 |
The Head Office fit out costs have been included in the fixtures, fittings and equipment category.
The Trustees agreed to sell one freehold shop during 2019, and a flat above another shop in 2020, both of which remained unsold at 31st December 2020 and are held for sale within current assets on the balance sheet.
94
95
14 Creditors: amounts falling due within one year
11 Programme related investment
| 2020 2019 |
|
|---|---|
| Investment in Fibrx Derm Inc Impairment Net Investment Value |
£ £ 190,840 - ( 190,839) - |
| 1 - |
The Trustees invested £190,840 ($250,000) in Fibrx Derm Inc, a US biotech company, purchasing 203,252 series A-2 convertible preferred stock, at a price of $1.23 per share. This investment supported the development of a new treatment to help wound healing in patients suffering from Dystrophic Epidermolysis Bullosa. The purpose of this investment was in furtherance of the charitable objectives of the charity, and no financial return was expected. The value of the investment has been impaired by 99.99% as the most prudent course of action.
12 Investment in short term deposits
----- Start of picture text -----
2020 2019
----- End of picture text -----
| 2020 2019 |
|
|---|---|
| Lloyds money market deposits | £ £ - 3,750,000 |
| - 3,750,000 |
----- Start of picture text -----
2020 2019
----- End of picture text -----
| 2020 2019 |
|
|---|---|
| Trade creditors Grants payable Other creditors Taxation and social security Accruals Deferred income |
£ £ 678,754 669,803 2,158,6572,201,344 308,617 6,226 92,476 96,107 917,315 692,069 26,900 115,631 |
| 4,182,719 3,781,180 |
Grants payable includes £790,811 (2019: £875,173) relating to future commitment and £1,436,558 (2019: £1,320,047) relating to outstanding invoices for work done.
There was deferred income of £26,900 in 2020 (2019: £115,631), representing income for events which would have to be repaid in the event of cancellation.
During the year we discovered that certain employee benefits had historically been mis-categorised as expenses resulting in an underpayment of income tax and national insurance. We also discovered that in 2019 and 2020 we had over-recovered VAT. We voluntarily reported both matters to HMRC during 2020 and paid a total sum of £64,341 in 2021 in settlement of these disclosures. This figure is included in other creditors. In voluntarily reporting these matters, we avoided having any penalties applied.
13 Debtors
----- Start of picture text -----
2020 2019
----- End of picture text -----
| 2020 2019 |
|
|---|---|
| HMRC Misc debtors Other debtors Accrued income Prepayments |
£ £ 281,158 259,632 387,844 210,306 48,653 295,263 363,233 550,443 535,731 611,059 |
| 1,616,6191,926,703 |
Payments due from HMRC are VAT payable of £216,811 (2019: £259,632), plus £64,347 (2019: 0) from the Coronavirus Job Retention Scheme. Miscellaneous debtors includes £266,825 (2019: £197,612) due for shared research grants. Other debtors includes £34,176 (2019: £216,884) profit due from the trading subsidiary. Accrued income includes gift aid of £147,660 (2019: £278,092) due from HMRC.
Creditors: amounts falling due over one year
----- Start of picture text -----
2020 2019
----- End of picture text -----
| 2020 2019 |
|
|---|---|
| Grants payable | £ £ 599,474 546,951 |
| 599,474 546,951 |
There was a dilapidations provision of £181,810 (2019: £241,812). In the year £81,422 was released from the provision and a further £21,420 was charged. It is uncertain when this provision will be spent.
Total future minimum lease receivable was £3,413 in 2020 (2019: £3,388), in respect of one shop and one flat above a shop.
96
97
16 Analysis of funds
15 Other financial commitments
The following payments are committed to be paid in the future in respect of operating leases:
----- Start of picture text -----
2020 2019 2020 2019
----- End of picture text -----
| 2020 2019 2020 2019 |
|
|---|---|
| Within 1 year Within 2-5 years After 5 years |
Leases of land and buildings Leases of land and buildings Other Other £ £ £ £ 1,264,152 1,617,494 15,274 22,394 1,170,587 1,421,057 29,332 5,283 5,250 58,029 - - |
| 2,439,989 3,096,580 44,606 27,677 |
There were capital commitments of £1,200 (2019: £0) at year end, falling due within one year.
Restricted funds
----- Start of picture text -----
Balance at Income Expenditure Transfer Balance at
31 Dec to General 31 Dec
2019 Fund 2020
----- End of picture text -----
2019 Fund 2020 |
|
|---|---|
| Research Healthcare Community Support & Respite Public Education |
£ £ £ £ £ - 182,771 (104,103) (78,668) - 79,477 26,223 (100,100) - 5,600 134,099 292,599 (355,755) - 70,943 - 13,824 (13,824) - - |
| 213,576 515,417 (573,782) (78,668) 76,543 |
Transfers to the general fund occurred following restricted income received in the current year for projects fully committed in the accounts in a prior year.
| Balance at 31 Dec 2018 Income Expenditure Transfer to General Fund Balance at 31 Dec 2019 |
|
|---|---|
| Research Healthcare Community Support & Respite |
£ £ £ £ £ 300 150,551 (123,851) (27,000) - 39,245 268,951 (228,719) - 79,477 96,690 366,067 (170,818) (157,840) 134,099 |
| 136,235 785,569 (523,388) (184,840) 213,576 |
98
99
17 Analysis of funds
Restricted funds comprised:
----- Start of picture text -----
2020 2019
----- End of picture text -----
| 2020 2019 |
|
|---|---|
| Healthcare - EB Nurses Healthcare - Birmingham Children’s Hospital Specialist Bath Community Support - Community Suppport Manager for Scotland Community Support - Community Support Manager Post Community Support - Community Support in Berkshire Community Support - Support Grants in Northamptonshire Community Support - Support Grants in Hampshire Community Support - Support Grants in Scotland Community Support - Support Grants in South Gloucestershire Community Support - other restricted funds |
£ £ 73,877 5,600 5,600 37,259 60,000 10,496 56,167 8,048 8,476 962 2,400 5,502 1,550 1,934 - 1,356 - 5,386 5,506 |
| 76,543 213,576 |
Unrestricted funds
The Trustees have transferred the following amounts into designated funds during 2020:
| Balance at 31 Dec 2019 Transfers Income Expenditure Balance at 31 Dec 2020 |
|
|---|---|
| Future research grants Nursing Continuity EB2020 conference Total designated funds General fund Total unrestricted funds |
£ £ £ £ £ 2,618,290 (1,339,000) - (763,340) 515,950 250,000 - - - 250,000 38,467 (56,027) 75,771 (58,211) - |
| 2,906,757 (1,395,027) 75,771 (821,551) 765,950 2,231,188 1,473,695 10,821,709 (12,388,095) 2,138,497 |
|
| 5,137,945 78,668 10,897,480 (13,209,646) 2,904,447 |
|
| Balance at 31 Dec 2018 Transfers Income Expenditure Balance at 31 Dec 2019 |
|
| Future research grants Nursing Continuity EB2020 conference Total designated funds General fund Total unrestricted funds |
£ £ £ £ £ 1,948,840 1,355,000 - (685,550) 2,618,290 250,000 - - - 250,000 229,827 - 264,717 (456,077) 38,467 |
| 2,428,667 1,355,000 264,717 (1,141,627) 2,906,757 1,991,410 (1,170,160) 15,747,613 (14,337,687) 2,231,188 |
|
| 4,420,077 184,840 16,012,330 (15,479,314) 5,137,945 |
The funds held in excess of the minimum cash-backed reserves as stated in the Reserves Policy have been designated by the Trustees to be expended on future research grants in line with the charitable objectives of the charity. In the light of the coronavirus pandemic the Trustees undesignated £1,397,000 from this fund to the general fund to contribute towards the running costs of the charity. It is anticipated this fund will be spent in the next year.
The designated fund for nursing continuity has been established as a contingency in the event of future
100
101
NHS funding withdrawal, and the Trustees maintained a balance of £250,000 in this fund in 2020.
19 Reconciliation of net income to net cash flow from operating activities
In 2018 the Trustees established a designated fund for the EB2020 conference, which was hosted by DEBRA in the UK in January 2020. £300,000 was designated to this fund in 2017 and 2018. During 2020 income of £75,771 was added to this fund and £58,211 was spent. The balance of £56,027 in this fund was transferred to the designated fund for future research.
18 Analysis of net assets between categories of funds
----- Start of picture text -----
Unrestricted Restricted Total Total
funds funds 2020 2019
----- End of picture text -----
| Fund balances at 31 December 2020 are represented by: Fixed assets Current assets Creditors: amounts falling due within one year Creditors: amounts falling due over one year |
£ £ £ £ 1,077,949 - 1,077,949 1,262,262 6,790,499 76,543 6,867,042 8,659,202 (4,182,719) - (4,182,719) (3,781,180) (781,282) - (781,282) (788,763) 2,904,447 76,543 2,980,990 5,351,521 |
|---|---|
----- Start of picture text -----
Unrestricted Restricted Total Total
funds funds 2019 2018
----- End of picture text -----
| Fund balances at 31 December 2019 are represented by: Fixed assets Current assets Creditors: amounts falling due with- in one year Creditors: amounts falling due over one year |
£ £ £ £ 1,262,262 - 1,262,262 1,099,016 8,445,626 213,576 8,659,202 7,617,553 (3,781,180) - (3,781,180) (3,223,805) (788,763) - (788,763) (936,452) 5,137,945 213,576 5,351,521 4,556,312 |
|---|---|
----- Start of picture text -----
2020 2019
----- End of picture text -----
| 2020 2019 |
|
|---|---|
| Net income for the reporting period (as per the statement of fnancial activities) Depreciation and amortisation charges Impairment of programme related investment Dividends, interest and rents from investments Proft on disposal of fxed assets Decrease in stock Decrease in debtors Increase in creditors |
£ £ (2,370,531) 795,209 162,872 138,758 190,839 - (47,403) (56,544) (6,777) 3,313 390 11,838 310,084 278,285 394,057 409,684 |
| (1,366,471) 1,580,543 |
20 Analysis of cash and cash equivalents
| As at 1 Jan 2020 Cash Flows As at 31 Dec 2020 |
|
|---|---|
| Cash at bank and in hand Total |
£ £ £ 2,898,199 2,178,354 5,076,553 |
| 2,898,199 2,178,354 5,076,553 |
An analysis of changes in net debt note has not been prepared on the basis that DEBRA only has cash and cash equivalents, the movement on which is shown above.
102
103
Grants to institutions continued
21 Grants to institutions
----- Start of picture text -----
Total paid Total paid Total
in 2020 to date committed
project cost
----- End of picture text -----
| Research projects: University of Dundee 1. Clinical fellow funding University of Glasgow 1. Mechanisms of TGF-beta mediated tumour protectin in RDEB Guy’s and St Thomas’ Hospital, London 1. Validated clinical endpoints study re EB therapy evaluation 2. Stem cell therapy trial to investigate treating debilitating itch 3. Wound care and its complications in patients with EB Thomas Jefferson University, Philadelphia, USA 2. Phase 2 clinical trial of Rigosertib for RDEB SCC University of Birmingham Dental School & Hospital 1. Characterisation of skin microbiome in EB patients 2. Gait Analysis in EB Simplex 3. Clinical Fellowship 4. Novel spray to treat mucosal scarring University of Cologne 1. Exploring immunity in wound healing complications in RBEB |
£ 89,572 |
£ 504,474 |
£ 504,474 |
|---|---|---|---|
| 78,525 | 157,138 | 157,138 | |
| 120,717 113,262 - |
533,601 465,414 - |
734,790 497,360 112,500 |
|
| 233,979 | 999,015 | 1,344,650 | |
| 40,984 | 470,490 | 470,490 | |
| 113,500 - 35,114 25,406 |
264,930 - 35,114 25,406 |
296,289 46,030 125,263 152,385 |
|
| 174,020 | 325,450 | 619,967 | |
| 57,462 | 141,018 | 170,635 |
| Universitair Medisch Centrum Groningen 1. Effectiveness of phyto-cannabinoid treatment of pain in EB Instituto Dermopatico deli’Immacolata Rome 1. Anti-fbrotic potential of histone deacetylase inhibitors for RDEB King’s College London 1. Preclinical studies of lentiviral-mediated COL7A1 gene therapy Great Ormond Street Institute of Child Health 1. Respiratory cell and gene therapy for children with junctional EB Bambino Gesù Children’s Hospital 1. MicroRNAs expression profling, activity and therapeutic perspectives University of Edinburgh 1. Understanding role of Kindlin-1 loss in squamous cell carcinoma New York Medical College 1. Identifying innate and adaptive immune mechanisms in RDEB Other Decrease in research provision Grants written off at end of project Total research grants Research project expenditure by category: Pre-clinical development Clinical investigation Patient treatment study |
47,300 | 159,025 | 159,025 |
|---|---|---|---|
| 32,729 | 59,780 | 70,963 | |
| 84,044 | 145,189 | 174,023 | |
| - | - | 135,338 | |
| 14,680 | 14,680 | 77,592 | |
| 10,288 | 10,288 | 112,833 | |
| 34,644 | 34,644 | 207,538 | |
| (244,775) | - - |
- - |
|
| 653,452 | 3,021,191 | 4,204,666 | |
| 182,575 269,331 201,546 |
1,555,381 1,202,372 1,126,875 |
||
| 653,452 | 3,884,628 |
104
105
----- Start of picture text -----
Total paid in Total
2020 project cost
----- End of picture text -----
| Healthcare projects: Great Ormond Street Hospital for Sick Children Clinical nurse specialists in EB Guys & St Thomas’ Hospital London Adult EB support nurses Clinical best practice guidelines on parenteral and enteral feeding Other Birmingham Children’s Hospital Miscellaneous Total Healthcare Team grants |
£ £ 66,176 66,176 79,647 80,288 39,996 38,000 56,148 56,394 - 22,891 |
|---|---|
| 241,967 263,748 |
22 Related parties
The principal activities of DEBRA Trading Ltd (company number: 2487114), a company incorporated in England and Wales, are the sale of promotional items on behalf of DEBRA, a house clearance service and corporate sponsorship. DEBRA has a beneficial interest in 100% of the company’s issued share capital of £2.
----- Start of picture text -----
2020 2019
----- End of picture text -----
| £ | £ | |
|---|---|---|
| Turnover | ||
| 96,247 | 307,231 | |
| Net proft gift aided to DEBRA | ||
| 34,176 | 216,884 | |
| Net assets | ||
| 2 | 2 |
During the year, the charity charged management charges totalling £7,200 including VAT (2019: £7,200) to its subsidiary, DEBRA Trading Limited.
----- Start of picture text -----
Louise Bellaers Photography
----- End of picture text -----
106
107
Reference and administrative details
Patrons and Ambassadors
Royal Patron Life Patron President Vice Presidents HRH The Countess of Wessex Philip Evans Simon Weston Graeme Souness, Frank Warren Trustees Chair Treasurer Jim Irvine Joanne Merchant Vice-Chairs Graham Marsden & Carly Fields (from 13.02.20) Trustees Christo Kapourani David Bendor-Samuel Vivien Mundy Simone Bunting (until 22.07.2020) Timothy Powell Rebecca Cresswell Douglas Rouse (from 01.07.2020) Simon Cuzner Michael Thomas (from 01.07.2020) Andrew Grist David Wilkinson (until 23.01.2020) James Hinchcliffe (until 26.06.2020)
Senior Management Team
Chief Executive Director of Fundraising & Communications Ben Merrett (until 30.06.20) Hugh Thompson Tony Byrne (from 12.10.2020) Director of Human Resources Director of Research Louise Westphalen Caroline Collins (until 27.11.2020) Director of Finance Carol Harris Director of Healthcare, Membership & Community Support Company Secretary Claire Mather Dawn Jarvis
Director of Retail
Chantelle Milne
Additional details
Charity Commission Number 1084958
Auditor Sayer Vincent LLP, Invicta House, 108-114 Golden Lane, London EC1Y 0TL
OSCR Number SC039654
Banker
HSBC, Thames Valley Business Banking, Hanborough House, Wallbrook Court, North Hinskey, Oxford, OX2 0QS
Company Number 4118259
Registered office & principal address DEBRA, The Capitol Building, Oldbury, Bracknell, RG12 8FZ
Solicitor
Stone King, 91, Charterhouse Street, London, EC1M 6HR
Abbreviations
| CPG | Clinical Practice Guideline |
|---|---|
| CEO | Chief Executive Offcer |
| DEB | Dystrophic Epidermolysis Bullosa |
| EB | Epidermolysis Bullosa |
| EBS | Epidermolysis Bullosa Simplex |
| EDI | Equality, Diversity & Inclusion |
| F&E | Furniture & Electrical retail store |
| GDPR | General Data Protection Regulation |
| HR | Human Resources |
| k | thousand |
| LFL | like-for-like |
| m | million |
| NHS | National Health Service |
| pa | per annum |
| RDEB | Recessive Dystrophic Epidermolysis Bullosa |
| SMT | Senior Management Team |
| Temporary shop | any shop that has a notice period of one year or less, where notice |
| can be served by the landlord and has a tenure of: holding over (England), | |
| holding over by licence, lease with rolling break, licence, licence with rolling | |
| break, tacit relocation, tenancy at will. | |
| y on y | year on year |
| PPE | Personal Protective Equipment |
| HMRC | HM Revenue and Customs |
108
109
DEBRA funds pioneering research, specialist healthcare, international best practice and lifelong care and support to the EB Community. We make a difference today with the aim of a better future for those suffering from the condition. Together we #FightEB.
Facebook: /DEBRACharity Twitter: @charitydebra Instagram: @charitydebra
www.debra.org.uk | 01344 771961 | debra@debra.org.uk
DEBRA, The Capitol Building, Oldbury, Bracknell, Berkshire RG12 8FZ
DEBRA A charity registered in England and Wales (1084958) and Scotland (SC039654). Company limited by guarantee registered in England (4118259). VAT Number 689 2482 79.
110
Issuer
DEBRA
Document generated Thu, 29th Apr 2021 9:44:46 BST
Document fingerprint bf8d4c3d3754c40cd089850be38ddb42
Parties involved with this document
Document processed
Party + Fingerprint
Thu, 29th Apr 2021 9:48:30 BST Thu, 29th Apr 2021 12:21:33 BST Thu, 29th Apr 2021 12:22:30 BST
Carol Harris - Signer (5d581ab8c005eea510d7882c773b5a96) Jim Irvine - Signer (c70f668949a3c5c2660a9d3079e0e655) Joanne Merchant - Signer (ee649f8c9454a28654f97e55ad2e2db4)
Audit history log
Date
Action
Thu, 29th Apr 2021 12:22:30 BST Thu, 29th Apr 2021 12:22:30 BST Thu, 29th Apr 2021 12:21:56 BST Thu, 29th Apr 2021 12:21:49 BST Thu, 29th Apr 2021 12:21:34 BST Thu, 29th Apr 2021 12:21:33 BST
Thu, 29th Apr 2021 12:21:33 BST Thu, 29th Apr 2021 12:18:25 BST Thu, 29th Apr 2021 9:48:30 BST Thu, 29th Apr 2021 9:48:30 BST
Thu, 29th Apr 2021 9:48:30 BST Thu, 29th Apr 2021 9:47:42 BST Thu, 29th Apr 2021 9:47:12 BST Thu, 29th Apr 2021 9:47:11 BST
Thu, 29th Apr 2021 9:46:36 BST Thu, 29th Apr 2021 9:46:36 BST
The envelope has been signed by all parties. (31.53.64.153) Joanne Merchant signed the envelope. (31.53.64.153) Joanne Merchant viewed the envelope. (31.53.64.153) Joanne Merchant opened the document email. (31.53.64.153) Document emailed to joanne.merchant@debra.org.uk (18.132.9.15) Sent the envelope to Joanne Merchant (joanne.merchant@debra.org.uk) for signing. (185.164.181.131) Jim Irvine signed the envelope. (185.164.181.131) Jim Irvine viewed the envelope. (185.164.181.131) Document emailed to jim.irvine@debra.org.uk (3.8.19.21) Sent the envelope to Jim Irvine (jim.irvine@debra.org.uk) for signing. (81.156.41.172)
Carol Harris signed the envelope. (81.156.41.172) Carol Harris viewed the envelope. (81.156.41.172) Document emailed to carol.harris@debra.org.uk (18.130.127.192) Sent the envelope to Carol Harris (carol.harris@debra.org.uk) for signing. (81.156.41.172)
Joanne Merchant has been assigned to this envelope (81.156.41.172) Jim Irvine has been assigned to this envelope (81.156.41.172)
Thu, 29th Apr 2021 9:46:36 BST Carol Harris has been assigned to this envelope (81.156.41.172) Thu, 29th Apr 2021 9:44:53 BST Document generated with fingerprint bf8d4c3d3754c40cd089850be38ddb42 (81.156.41.172) Thu, 29th Apr 2021 9:44:46 BST Envelope generated by Carol Harris (81.156.41.172)